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1. Introduction 
Bipolar disorder is a severe psychiatric illness characterized by cyclic episodes of mania and 
depression that affects approximately 1 % of the world population, and has a great 
economic and social impact. Lithium (Li+), in the form of lithium salts, has been used for 
more than five decades and  is still the drug of choice in the treatment of this pathology. The 
 anticonvulsants  carbamazepine  and  valproate,  originally  used  to  treat  epileptic 
 seizures,  are alternative or adjunctive therapies to lithium, representing the first-line 
therapy for lithium-resistant or lithium intolerant  patients.  Bipolar disorder is associated 
with structural, functional and physiological alterations in the brain of bipolar patients, 
which reflect chemical, neurochemical and metabolic changes, specifically at the levels of 
brain metabolites and neurotransmitters, as already detected by different techniques 
(Silverstone et al., 2005). Abnormalities in signal transduction pathways, in particular G 
proteins, adenylate  cyclase  (AC) and phosphatidylinositol (PI) signalling cascade, as well 
as protein kinase C (PKC) were related with the pathophysiology of bipolar disorder (Berns 
& Nemeroff, 2003, Brunello & Tascedda, 2003; Manji et al., 2001; Manji & Lenox, 2000a, 
2000b).   
Despite  the  widespread  clinical  use  of lithium  salts,  the  pharmacological  mode  of 
 action  underlying  Li+ mood stabilizing  effects  is  still  unclear  and several hypotheses 
have been advanced. Once inside the cells, Li+ has been proposed to compete with Na+ and 
Mg2+ for these ions intracellular binding sites in biomolecules, to affect intracellular Ca2+ 
concentration and to have an important role on the activity of G proteins, AC and inositol 
monophosphatase (IMPase) thus interfering with the levels of neurotransmitters and other 
substances in brain. Li+ has also been proposed to modulate the activity of certain glycolytic 
and tricarboxylic acid (TCA) cycle enzymes affecting several metabolic pathways and 
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altering the concentrations of intermediary metabolites. Recent research has been  focused 
 on how Li+ changes  the  activity  of  cellular  signal  transduction  systems,  in particular 
 those  involving AC. The present chapter is a review of data published in literature from 
studies carried out to test some of these hypotheses, which, in most cases, are inter-related. 
The objective is to give an overview of what is known about possible mechanisms of Li+ 
therapeutic action in bipolar disorder, at the molecular and cellular levels, using different 
approaches and techniques. 
Li+ effects have been shown to be highly cell-type specific and so the study of Li+ transport 
processes across cell membranes is pertinent. Studies of the kinetics of Li+ influx, 
intracellular immobilisation and Li+/Mg2+ competition in different types of cells are 
presented (Amari et al., 1999a; Castro et al, 1996; Fonseca et al., 2000, 2004; Layden et al., 
2003; Montezinho et al., 2002; Mota de Freitas et al., 2006; Nikolakopoulos et al., 1998). Li+ 
influx rate constants were determined by atomic absorption spectrophotometry 
(experiments performed in cell suspensions) and 7Li nuclear magnetic resonance (NMR) 
spectroscopy (cells immobilized in agarose), in the presence and absence of different 
activators and inhibitors of transport pathways present in these cells membrane. L-type 
voltage-sensitive Ca2+ channels were found to have an important role in Li+ uptake under 
depolarising conditions in excitable cells. Once inside the cells, Li+ was found to be bound to 
intracellular structures, as demonstrated by the ratio between the intracellular 7Li NMR 
longitudinal and transversal relaxation times (T1/T2 ratio). The degree of intracellular Li+ 
immobilisation is cell type dependent. Intracellular Mg2+ was found to be significantly 
displaced by Li+ from its binding sites, as demonstrated by 31P NMR and fluorescence 
spectroscopy (Fonseca et al., 2004) 
The study of the effects of Li+ on metabolic pathways is also referred. Results for Li+ effects 
on glucose metabolism and on the competitive metabolism of glucose and lactate in a cell 
line, the human neuroblastoma SH-SY5Y cells, using 13C NMR spectroscopy are presented 
(Fonseca et al., 2005). A relatively simple metabolic network was proposed for these cells, 
based on the computer program tcaCALC best fitting solutions. The results obtained 
suggested that cell energetic metabolism might be an important target for Li+ action. 13C 
NMR spectroscopy was also used to investigate Li+ effects on glucose and acetate 
metabolism in primary cell cultures, rat cortical neurons and astrocytes, as well as in rat 
brain (Fonseca et al., 2009). It was proposed that Li+ has an important role on the GABAergic 
neurotransmitter system as detected in cortical neurons when 13C-glucose was used as 
substrate, as well as in rat brain after infusion with [1-13C]glucose. 
Since  it  has  been  suggested  that  cyclic  adenosine  3’,5’monophosphate  (cAMP)  levels 
 are  abnormal  in  bipolar patients  and  are  regulated  by  mood  stabilizing  agents,  it  is 
 of  utmost importance  to  know  whether  this  second messenger  regulates  Li+ transport 
 into  neurons. It is also relevant to determine Li+ effects on the homeostasis of intracellular 
cAMP levels. The effect  of  different intracellular  cAMP levels on  Li+ uptake,  at 
 therapeutic  plasma concentrations, was studied using pertinent cellular models and a 
radioactive assay (Montezinho et al., 2004). The data obtained demonstrated  that 
 intracellular  cAMP  levels  regulate  the  uptake  of  Li+  in  a  Ca2+ dependent  manner, and 
that  Li+ plays  an  important  role  in  the  homeostasis  of  this  second  messenger  in 
 neuronal  cells . 
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Second messenger-mediated pathways are targets for Li+ action, thus, it is important to 
investigate whether other mood stabilizing agents exert similar effects on the same 
signalling pathways. Bipolar disorder seems to be associated with an enhanced 
signalling activity of the cAMP cascade and most of its events have been implicated in 
the action of mood stabilizing agents. Therefore the effects of Li+, carbamazepine and 
valproate on basal and forskolin-evoked cAMP accumulation and the capacity of 
dopamine D2-like receptors stimulation, with quinpirole, to block the increase of 
forskolin-stimulated cAMP levels were studied both in vitro, in cultured cortical neurons, 
and in vivo in the rat prefrontal cortex using microdialysis in freely moving animals, 
under control conditions and after treatment with  the mood stabilizing drugs 
(Montezinho et al., 2006). 
Several  studies  have  suggested  the  involvement  of  biogenic  monoaminergic 
 neurotransmission  in  bipolar disorder and  in  the  therapies  used  for  this  disease. The 
effects of the mood  stabilizing  drugs  Li+,  carbamazepine or valproate  on  the 
 dopaminergic  and  adrenergic  systems, particularly on  dopamine  D2-like and -
adrenergic receptors,  were  studied  both  in  cultured  rat  cortical  neurons  and  in  the  rat 
 prefrontal  cortex  using  microdialysis in  freely  moving  animas (Montezinho et al., 2007). 
It was observed that these receptors have a regulatory role on AC activity and each drug 
acts by a unique mechanism. Dopamine  D2  and  1-adrenergic receptors were  found to be 
co-localized in cells of the prefrontal cortex, as determined by immunohistochemistry and 
were differentially affected by treatment  with  the  three  mood  stabilizers, as determined 
 by Western blot experiments. Data showed that the mood  stabilizers  studied  affected 
 dopamine D2 receptors.  
Figure 1 summarizes the possible targets for Li+ action. 
2. Characterisation of Li+ transport pathways and intracellular binding: 
Effects on Li+/Mg2+ competition in cellular models 
Li+ transport, intracellular immobilisation and Li+/Mg2+ competition were studied in 
chromaffin cells, isolated from the bovine adrenal medulla, which are good neuronal models 
(Trifaró, 1982), and human neuroblastoma SH-SY5Y cells, a clonal derivative of the SK-N-
SH cell line that provides a suitable model of neurons due to its exclusive neuroblast 
phenotype (Biedler et al, 1973). The results obtained and the main conclusions are presented 
in the following sections. 
2.1 Li+ membrane transport studies in neuronal models 
Atomic Absorption (AA) spectrophotometry was used to investigate the membrane 
transport pathways involved in the uptake of Li+ by chromaffin cells (Fonseca et al., 2004). 
Figure 2 shows the kinetics of Li+ influx in the control situation, in the presence of ouabain 
(a (Na+, K+)-ATPase inhibitor), and under continuous depolarising conditions in the absence 
and presence of nitrendipine (a specific blocker of the L-type voltage-sensitive Ca2+ 
channels). The kinetics of Li+ influx was analysed using the following equation: 
 ([Li+]iT)t = ([Li+]iT ) [1 – exp(–kit)]  (1) 
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where ki is the rate constant for Li+ influx, ([Li+]iT)t and ([Li+]iT) are the total intracellular Li+ 
concentrations at the different time points t and when the steady state has been reached, 
respectively. 
 
 
 
 
 
 
(A) (B) 
 
 
 
 
 
Fig. 1. Some potential targets for Li+ action inside the cells. A) Li+ is transported across the 
cell membrane, through specific transport systems already present in the membrane or by 
passive diffusion. Li+ has been proposed to bind the negatively charged groups of several 
membrane phospholipids modulating the activity of membrane proteins and possibly ion 
transport processes. Li+ can also affect the intracellular Ca2+ concentration ([Ca2+]i) and 
compete with mono- and di-cations, such as Na+ and Mg2+, respectively, for their 
intracellular binding sites. Other possible targets for Li+ action are guanine-nucleotide 
binding proteins (G-proteins), adenylate cyclase (AC) and inositol monophosphatase 
(IMPase), affecting in this way the levels of second messenger molecules such as 3´,5’-cyclic 
adenosine monophosphate (cAMP), diacylglycerol (DAG) or inositol 1,4,5-triphosphate 
(IP3), and the metabolism of phosphatidylinositols. Li+ has also been proposed to modulate 
the activity of some glycolytic and tricarboxylic acid (TCA) cycle enzymes and the levels of 
some metabolic intermediates. , β and  – subunits of G-proteins; A – agonist; ATP – 
adenosine triphosphate; mR – metabotropic receptor; [Mg2+]i and [Na+]i – intracellular Mg2+ 
and Na+ concentrations, respectively; PIP2 – phosphatidylinositol 4,5-bisphosphate; PKA – 
protein kinase A; PKC – protein kinase C; PLC – phospholipase C. B) It is known that 
multiple inter-related neurotransmitter systems are involved in mood regulation. Thus, Li+ 
can affect the functional equilibrium between several interacting systems. This figure shows 
the processes which seem to have an important role in the mechanisms of mood 
stabilization. R1, R2= post-synaptic receptors;   = neurotransmitters (Jope, 1999a; Manji et 
al., 1995; Manji et al., 2001) 
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Experimental conditions ki (min-1) [Li+]iT (mmol (L cells)-1)
Control
+50 µmolL-1 ouabain
+45 mmolL-1 KCl
45 mmolL-1 KCl+10molL-1 nitrendipine
0.040  0.006 (n=14)
0.036  0.005 (n=7)
0.110  0.038 (n=5)**
0.038  0.007 (n=8)#
11.39  0.56
8.38  0.38*
4.16  0.27***
4.14  0.28
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Fig. 2. A) Graphical representation of the [Li+]iT (determined by AA spectrophotometry) versus 
loading time during Li+ influx experiments in bovine chromaffin cells in suspension (cytocrit 
of 2 to 3%) subject to loading with 15 mmol L-1 Li+, at 37 ºC. Data are for control (), in the 
presence of 50 mol L-1 ouabain (), in the presence of 45 mmol L-1 KCl, a depolarising agent 
(), and in the presence of 45 mmol L-1 KCl and 10 mol L-1 nitrendipine (). The lines 
correspond to the best exponential fits of the data to equation 1. In all cases, the intracellular 
Li+ concentration increases up to 60–90 min and then reaches a steady state, except for the 
experiment done under depolarising conditions without nitrendipine, where the steady 
state is reached at 30 min; B) Li+ influx rate constants (ki) and the steady state total 
intracellular Li+ concentrations ([Li+]iT), obtained from the curves presented in A), using 
equation 1. The values are average  SEM for the number (n) of trials indicated in parenthesis. 
*, ** and ***: p < 0.05, p < 0.01 and p < 0.001 relative to control, respectively; # p < 0.05 relative 
to the KCl condition. (Fonseca et al., 2004) 
In these experiments, the kinetics of Li+ influx is not affected by the presence of ouabain, 
which suggests the non-involvement of (Na+,K+)-ATPase in Li+ uptake by chromaffin cells, 
under resting conditions. However, when the cells are depolarised with KCl, a significant 
increase in the ki value is observed, an effect that is completely suppressed in the presence of 
nitrendipine. This indicates that, under increased cellular excitability conditions, a new 
contribution to Li+ influx appears which results from the activation of L-type voltage-
sensitive Ca2+ channels. When the cells are depolarised, the intracellular Ca2+ concentration 
largely increases, increasing the activity of the Na+/Ca2+ exchanger, known to be a high–
capacity, low-affinity mechanism of Ca2+ efflux (Kao & Cheung, 1990; Powis et al., 1991). In 
our experiments, we propose that the Na+/Ca2+ exchanger uses the external Na+ and Li+ to 
remove intracellular Ca2+ accumulated during cell depolarisation. Blocking of the L-type 
voltage-sensitive Ca2+ channels by nitrendipine prevents the depolarisation-dependent Ca2+ 
entry through these channels and therefore depresses the activity of the Na+/Ca2+ 
exchanger, suppressing this new Li+ entry pathway. 
In the absence of active transport pathways for Li+ influx, the [Li+]iT obtained by AA 
spectrophotometry reflect the capacity of the cells to accumulate Li+, which is controlled by 
the plasma membrane potential (-55mV in these cells, under resting conditions (Friedman et 
al.,1985)). When depolarisation occurs, the membrane potential becomes less negative, and 
the total amount of Li+ that can be accumulated by the cells is lowered due to charge effects 
(Figure 2). This explains why the amount of Li+ accumulated by the cells is significantly 
lowered when they are directly depolarised by KCl. The [Li+]iT values observed under direct 
depolarising conditions in the presence and in the absence of nitrendipine are not 
significantly different, as expected, since under these conditions the membrane potential is 
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kept constant by the high extracellular K+ concentrations, even if nitrendipine affects the Li+ 
uptake kinetics. The observation that ouabain lowers the steady state [Li+]iT also shows its 
depolarising effect on these cells (Kitayama et al.,1990).  
2.2 Li+ degree of immobilisation inside cells by 7Li NMR  
The degree of immobilisation of Li+ within different types of cells was investigated using 7Li 
NMR relaxation measurements when the intracellular Li+ concentration has reached a 
steady-state. Therefore, Li+ uptake was first followed by 7Li NMR spectroscopy, along with 
the shift reagent [Tm(HDOTP)]4- in cell suspensions and in agarose-embedded and perfused 
cells. The shift reagent was used to separate 7Li NMR signals corresponding to Li+ inside 
and outside the cells (Nikolakopoulos et al., 1998; Rong et al., 1993). Figure 3 shows 7Li 
NMR spectra from an influx experiment performed in agarose gel-embedded bovine 
chromaffin cells, under the experimental conditions indicated in figure legend. A graphical 
representation of the percent of intracellular 7Li resonance area, Ai, relative to the total area 
of intra- and extracellular 7Li resonances, Ai + Ae, over time is shown in Figure 3 C. The 
kinetics of Li+ influx was defined by equation 2: 
 [(Ai)t / (Ai + Ae)t] = [(Ai) / (Ai + Ae)] [1 – exp(–ki t)]                 (2) 
where ki is the rate constant for Li+ influx, (Ai)t, (Ae)t and (Ai), (Ae) are the areas of the 
intracellular and extracellular 7Li+ NMR signals at the different times t and when the 
intracellular Li+ concentration has reached a steady state, respectively. 
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Fig. 3. A) Chemical structure of [Tm(HDOTP)]4-; B)  7Li NMR spectra (194.3 MHz) obtained 
over time in a Li+ influx experiment performed with agarose gel-embedded bovine 
chromaffin cells (50 to 75  106) continuously perfused, at 1 mL min-1, with culture medium 
containing 15 mmol L-1 Li+ and 7 mmol L-1 [Tm(HDOTP)]4- (37 ºC). Each spectrum 
represents the average of the total accumulation time of 11 min. 7Li+e and 7Li+i are the extra- 
and intracellular 7Li NMR resonances, respectively. NMR experiments were performed on a 
Varian Unity-500 NMR spectrometer equipped with a multinuclear 10 mm broadband 
probe and a controlled temperature unit, using the following parameters: 64 transients for 
each spectrum, spectral width of 5.6 kHz, pulse width of 15 s, acquisition time of 0.360 s 
and recycling time of 10.36 s. The signal-to-noise ratio was enhanced by exponential 
multiplication with a line broadening of 30 Hz. C) Time dependence of the percentage of 
intracellular 7Li+ NMR signal area, normalised to the total area of intra- and extracellular 7Li 
NMR signals [(Ai)/(Ai + Ae)]. The experimental data was fitted using equation 2 and the line 
corresponds to the best exponential fit of the data (Fonseca et., 2004). 
www.intechopen.com
 Li+ in Bipolar Disorder – Possible Mechanisms of Its Pharmacological Mode of Action 
 
63 
For chromaffin cells immobilised in agarose gel threads, the influx rate constant has a 
contribution from the diffusion process of Li+ across the gel before reaching the cell 
membrane (Nikolakopoulos et al., 1996). Therefore, under these conditions, the value 
obtained from equation 2 for Li+ influx is an apparent ki value, kiapp. The average value 
obtained for kiapp was 0.012  0.003 min-1, much lower than the value determined for cell 
suspensions using AA spectrophotometry (0.040  0.006 min-1, Figure 2 B, (Fonseca et al., 
2004)) or 7Li NMR spectroscopy (0.040  0.003 min-1, (Fonseca et al., 2000)), as expected. 
Three hours after the beginning of the 7Li+ influx NMR experiments, when the steady 
state intracellular Li+ concentration was reached, the degree of immobilisation of Li+ 
inside different types of cells was investigated using 7Li NMR relaxation measurements 
by determining intracellular 7Li+ T1 and T2 values and the respective T1/T2 ratio. This ratio 
is a sensitive measure of the rotational correlation time, τc, of the Li+ ion, and hence of Li+ 
immobilisation, independently of the fraction of bound Li+ and of its binding affinity 
(Layden et al., 2003; Nikolakopoulos et al., 1998; Rong et al., 1993) (Figure 4). 
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Fig. 4. T1 and T2 dependence on the rotational correlation time (τc) of a molecule. ω0 stands 
for the Larmor angular frequency. When ω0τc << 1 (for small molecules or freely moving 
ions) T1 equals T2 and the T1/T2 ratio equals 1. When ω0τc = 1, T1 reaches its minimum value 
and for ω0τc >> 1 (large molecules or immobilised ions) T1 increases proportionally to τc 
while T2 decreases and the T1/T2 ratio becomes higher than 1 (Adapted from Gil & Geraldes, 
1987). 
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Table 1 compares the results obtained for different types of cells: 
 
Sample [Li+] b T1 (s) T2 (s) T1/T2 
Bovine chromaffin cells 
suspensions (n=5) c 
Bovine chromaffin cells 
perfused (n=4) d 
Neuroblastoma cells (n=3) e 
Lymphoblastoma cells (n=3) f 
Human red blood cells (n=3) g 
Viscosity adjusted LiCl solution g,i 
 
1.7 
 
11.4 
2.9 
3.1 
3.5 
4.0 
 
6.1  0.2 
 
5.4  1.3 
5.1  0.8 
2.6  0.4 
6.5  0.2 
3.9  0.4 
 
0.02  0.002 
 
0.05  0.006 
0.05  0.02 
0.06  0.01 
0.46  0.01 
3.6  0.6 
 
305  32 
 
106  28 
102 h 
43  4 
14 h 
1.1 0.2 
a Each T1 and T2 value is an average  SEM for the number (n) of trials indicated in parenthesis. b For the 
cell samples, this is the steady state total intracellular Li+ concentration of Li+-loaded cells, [Li+] iT, expressed 
as mmol (L cells)-1, with errors less than 10%. c Data from Fonseca et al., 2000. d Data from Fonseca et al., 
2004. e Data from Nikolakopoulos at al., 1998. f Data from Layden at al., 2003. g Data from Rong et al., 1993. h 
Errors are less than 10%. i Sample viscosity was adjusted to 5 centipoise (cP) with glycerol.  
Table 1. 7Li NMR relaxation timea and T1/T2 ratio values for intracellular Li+ obtained for 
different types of cells. 
The T1/T2 ratio obtained for bovine chromaffin cells, under the perfusion experimental 
conditions, is considerably lower than for the same cells in suspension at similar 
extracellular Li+ concentrations (15 mmol L-1) , indicating an increased degree of 
immobilization of Li+ in the latter case. This difference could reflect some loss of viability of 
the cells during the NMR experiments in cell suspensions without perfusion. The disruption 
of the cell membrane and the probable nonintegrity of the cytoplasm may contribute to a 
higher immobilization of this ion through binding to the cytoplasmatic membrane and 
intracellular structures. Comparing the T1/T2 ratios of the various perfused cell systems at 
similar Li+ loading levels (Table 1), the degree of Li+ immobilization follows the following 
order: chromaffin  neuroblastoma > lymphoblastoma > red blood cells (RBCs), reflecting 
the relative local mobility of the intracellular Li+ binding sites of the different systems.  
2.3 Monitorisation of agarose-embedded cells viability using 31P NMR spectroscopy 
Cell viability of the perfused agarose-embedded cells was monitored by obtaining 31P NMR 
spectra during the time course of the 7Li NMR experiments. Figure 5 shows representative 
1H-decoupled 31P NMR spectra obtained after Li+ NMR experiments in bovine chromaffin 
cells and neuroblastoma SH-SY5Y cells. 
The criteria used to evaluate cell viability during the NMR experiments were, in the case of 
SH-SY5Y cells, the intracellular levels of ATP and PCr over the course of the perfusion 
experiments (by monitoring the areas of the PCr and of the -, -, and -ATP 31P NMR 
resonances and the ratio of the PCr/-ATP areas) and the chemical shift of inorganic 
phosphate (Pi) which is related to the intracellular pH of the sample. The areas of the 31P 
NMR resonances of PCr and of ATP, as well as the chemical shift of the Pi resonance did not 
change appreciably during the course of NMR experiments, showing that there were no 
significant changes in energy metabolism or intracellular pH (Nikolakopoulos et al., 1998). 
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Fig. 5.  1H-decoupled 31P NMR spectrum (202.3 MHz) of Li+-loaded agarose gel-embedded 
SH-SY5Y cells, after 5 h perfusion (Nikolakopoulos et al., 1998) (A) or bovine chromaffin 
cells, after 7 h 30 min perfusion (Fonseca et al., 2004) (B). For SH-SY5Y cells, 31P chemical 
shifts are reported relative to phosphocreatine (PCr) referenced at 0 ppm. For chromaffin 
cells, H3PO4 85% was used as an external reference (0 ppm). PME: phosphomonoesters; Pi: 
inorganic phosphate; GPE: glycerophosphorylethanolamine; GPC: 
glycerophosphorylcholine; PCr: phosphocreatine; DPDE: diphosphodiesters; Sugars-P: 
sugars phosphate groups; - - and -ATP: ,  and  phosphate groups of ATP; P– and P–
ATPcyt:  and  phosphate groups, respectively, of cytosolic ATP; P–, P– and P–ATPgran: , 
 and  phosphate groups of granular ATP, respectively. 
In contrast to the SH-SY5Y cells, the 31P NMR spectrum of perfused bovine chromaffin cells 
shows compartmentation of ATP in the cytosol and inside the granules. The 31P NMR signal 
of cytosolic P-ATP is not observable, as it is part of the composite peak at – 10.8 ppm with 
the resonance from intragranular P-ATP, as well as from the vesicular P-ADP and the 
bisphosphate moiety of NAD+ and NADH (Painter et al., 1989). In the particular case of 
chromaffin cells, the criteria used to evaluate cell viability were the ratio of the areas of the 
P-ATP(cytosol) and Pi(cytosol) 31P NMR resonances (P-ATP(cytosol)/Pi(cytosol)) (which reflects the 
energetic state of the cells (Kaplan et al., 1989)), the chemical shift of the P-ATP(granule) 
resonance (which is related to the intragranular pH (Njus et al., 1978)), the observation of the 
cytosolic P-ATP and P-ATP signals (under good perfusion conditions, these resonances 
appear at approximately –4.5 and –18.4 ppm, respectively) and the area ratio P-ATP(cytosol)/ 
P-ATP(granule). The analysis of these parameters, as shown in Figure 5B), showed that the 
energetic state and the viability of perfused chromaffin cells were kept throughout the NMR 
experiments (Fonseca et al., 2004).  
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2.4 Li+/Mg2+ competition studies by 31P NMR and fluorescence spectroscopy 
It has been suggested that Li+ may compete with Mg2+ (a very well-known protein cofactor) 
for Mg2+ binding sites in several biomolecules, due to their similar chemical properties. 
Li+/Mg2+ competition have been studied in Mg2+-dependent biomolecules (e.g. ATP, ADP, 
GTP, GDP, IP3, G-proteins and phosphate groups of RBCs membrane phospholipids) and in 
cellular systems (such as Li+-loaded human RBCs and lymphoblastoma cells) using 
fluorescence spectroscopy with the Mg2+ indicator furaptra, as well as 7Li and 31P NMR 
spectroscopy (Amari et al., 1999b; Layden et al., 1999, 2003; Mota de Freitas et al., 1994, 2006; 
Ramasamy et al., 1989; Rong et al., 1994; Srinivasan et al., 1999).  
31P NMR spectroscopic method was used to examine the competition between Li+ and Mg2+ 
ions within intact human neuroblastoma SH-SY5Y cells. The 31P NMR method is based on 
the measurement of chemical shift difference changes between the 31P NMR resonances of 
the P and P phosphate groups () of ATP due to Mg2+ binding (Gupta et al., 1978). 
Upon Mg2+ binding to ATP, the  phosphate resonance is shifted downfield and the 
chemical shift difference between the  and  phosphates decreases (Amari et al., 1999a), 
being a parameter indicative  of Mg2+ binding to ATP and used to measure Li+/Mg2+ 
competition. The values of  were taken from 31P NMR spectra of Li+-loaded (Figure 5A) 
and Li+-free SH-SY5Y cells, and used to calculate intracellular free Mg2+ concentrations, 
[Mg2+]f, in both situations, as described in (Amari at al.,1999a). We found that the  
chemical shift in Li+-free cells was 8.67  0.02 ppm (n=3), whereas in Li+-loaded cells this 
difference increased significantly (p<0.0005) to 8.87  0.02 ppm (n=3), corresponding to a 
[Mg2+]f of 0.35 ± 0.03 mmol L-1 and  0.80 ± 0.04 mmol L-1, respectively (Amari et al.,1999a). 
The increase in [Mg2+]f after Li+ loading suggests that Li+ may compete with Mg2+ for its 
binding sites within the neuroblastoma cells. 
The 31P NMR method could not be used to study Li+/Mg2+ competition in bovine 
chromaffin cells due to some particular characteristics of these cells. In fact, ATP 
compartmentation in chromaffin cells causes the overlap of the P 31P NMR signals of 
cytosolic and granular ATP (Figure 5), preventing the use of this technique to determine 
[Mg2+]f in the cytosol of these cells. Concerning the granule, no effect of Li+ loading on the 
granular  value was observed, indicating no significant Li+/Mg2+ competition inside 
this organelle. Therefore, fluorescence spectroscopy using the Mg2+-specific fluorescent 
probe furaptra was the method of choice to study Li+/Mg2+ competition in these cells. 
According to established data (Amari et al., 1999a, 1999b), an increase in the ratio of 
fluorescence intensities at 335 nm and 370 nm, R = (F335/F370), during Li+ cell loading is 
indicative of the displacement of Mg2+ by Li+ from its binding sites, increasing the amount of 
intracellular free Mg2+ available to bind to furaptra (salt form) inside the cells. The R values 
can be converted into [Mg2+]f using equation 3, which corrects for Li+ binding to furaptra: 
[Mg2+]f = (Kd Smin (R – Rmin) / Smax (Rmax – R)) +  
(Kd S’max (R – R’max)[Li+]if / K’d S max (Rmax – R)) 
(3) 
where Rmin, Rmax and R’max are the ratios of the fluorescence intensities at 335 and 370 nm in 
the absence of metal ions and in the presence of saturating amounts of Mg2+ or Li+, 
respectively; Smin, Smax and S’max are the fluorescence intensities at 370 nm, respectively, in 
the absence of metal ions and in the presence of saturating amounts of Mg2+ or Li+; Kd and 
K’d are the dissociation constants of the furaptra-Mg2+ (1.5 mmol L-1 (Raju et al.,1989)) and 
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furaptra-Li+ (237 mmol L-1 (Amari et al., 1999b)) complexes, respectively. [Li+]if is the 
intracellular free Li+ concentration, corresponding to the Li+ ions capable of competing with 
Mg2+ for furaptra (Amari et al., 1999b). 
Figure 6 shows the fluorescence excitation spectra of furaptra in the presence of increasing 
concentrations of Mg2+ and a graphical representation of the time dependence of the R 
values for a control situation (in the absence of Li+) and for a 90 min Li+-loading experiment 
using a total Li+ concentration in the medium of 15 mmol L-1. 
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Fig. 6. A) Fluorescence excitation spectra of furaptra (0.2 mol L-1) in a modified Krebs 
medium (in mmol L-1: NaCl 140, KCl 5, glucose 10, HEPES 20, EGTA 0.5, pH 7.35) 
containing 0-10 mmol L-1 free Mg2+. The emission wavelength was fixed to 500 nm. The 
binding of Mg2+ to furaptra results in a blue shift in the excitation spectrum of this indicator 
from 370 to 335 nm with increasing amounts of Mg2+.  B) Time dependence of fluorescence 
intensity ratio R = (F335/F370) in bovine chromaffin cells previously loaded with furaptra, 
under control (Li+-free) conditions () and when the cells were incubated for 90 min with 15 
mmol L-1 Li+ (). Bovine chromaffin cells, adherent to a 1 cm2 square poly-L-lysine coated 
coverslip (0.8 × 106 cells per cm2) were placed in a fluorescence cuvette containing Krebs 
medium (in mmol L-1: NaCl 140, KCl 5, CaCl2 2, MgCl2 1, glucose 10, HEPES 20, pH 7.35). In 
the Li+ experiment, this medium was then replaced by a modified Krebs medium containing 
15 mmol L-1 Li+ (NaCl was partially replaced in order to maintain the osmolarity of the 
medium). During the experiments, the medium was changed every 15 min to remove any 
fluorescent probe that might have been released from the cells to the incubation medium, 
preventing the binding of the probe to the extracellular Mg2+, which would contribute to an 
overestimated value of [Mg2+]f (Fonseca et al., 2004). 
In the absence of Li+, the basal R value, which corresponds to [Mg2+]f = 0.54  0.01 mmol (L 
cells)-1 (n = 12), was maintained over time for 135 min. In the presence of Li+, the [Mg2+]f 
value was not significantly different from the control one ([Mg2+]f = 0.52  0.02 mmol (L 
cells)-1, n=6) at time zero of Li+ loading, but it significantly increased by 52% during the 90 
min of the Li+ loading process to a value of 0.79  0.05 mmol (L cells)-1 ([Mg2+]f = 0.27  0.05 
mmol (L cells)-1). In [Mg2+]f calculations it was considered the [Li+]if = 9.42  0.01 mmol (L 
cells)-1 obtained by 7Li NMR for immobilised, perfused cells at steady state, which was 
shown to be the most accurate value (Fonseca et al., 2004). The [Mg2+]f increase when Li+ 
enters the viable cells, observed by fluorescence spectroscopy, confirms the capacity of Li+ to 
displace Mg2+ from its intracellular binding sites. 
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The relative extent of Li+/Mg2+ competition, which is cell type and [Li+]iT dependent, may 
expressed by the percent [Mg2+]f increase divided by [Li+]iT (%([Mg2+]f/[Mg2+]f)/[Li+]iT 
ratio). This extent is higher for neuroblastoma cells, similar for chromaffin and 
lymphoblastoma cells, and lower for RBCs (Fonseca et al., 2004). Based on the relative 
percent [Mg2+]f increase/[Li+]iT ratio values reported above, we suggest that the extent of 
Li+/Mg2+ competition under pharmacological conditions is cell-type dependent, being 
affected by differences in Li+ transport and immobilisation properties. 
Li+/Mg2+ competition has been shown to occur at therapeutic intracellular Li+ levels (0.6–3.1 
mmol (L cells)-1) in human neuroblastoma SH-SY5Y cells (Layden et al., 2000). Changes in 
[Mg2+]f of the order of 10%, observed for these cells at [Li+]i = 0.6 mmol (L cells)-1, are 
expected to have a large impact on the many biochemical and cell signalling pathways 
involving Mg2+-dependent enzymes (Layden et al., 2003). Based on the experimentally 
observed proportional relationships in %([Mg2+]f/[Mg2+]f)/[Li+]i, much smaller percentage 
(3%) effects in [Mg2+]f are to be expected in chromaffin cells at [Li+]i = 0.6 mmol (L cells)-1, 
similar to those proposed for lymphoblastoma cells (3%) but still higher than for RBCs 
(1.5%) (Layden et al., 2003), which possibly will have an undetectable cell impact. 
In summary, 7Li NMR spectroscopy proved to be a useful tool to investigate Li+ transport, 
along with AA spectrophotometry, and intracellular binding in cellular models, whereas 31P 
NMR and fluorescence spectroscopy, using the Mg2+-specific fluorescent probe furaptra, 
allowed to quantify intracellular competition between Li+ and Mg2+ ions. These studies 
provide further evidence for the generality of the ionic competition mechanism, contributing 
to the understanding of the pharmacological action of Li+ at the molecular level. 
3. Metabolic effects of Li+ on neuronal and glial cells and rat brain 
3.1 Li+ effects on cell energetic metabolism 
Altered intracellular signalling systems are thought to play an important role in the 
pathophysiology of bipolar disorder (Jope, 1999b; Lenox & Hahn, 2000; Manji et al., 1995). 
Since these processes, as well as brain activity in general, closely depend on energy 
metabolism and ATP availability, changes in brain energy metabolism may also be involved 
in the pathogenesis of this disease. Neuroimaging techniques (mainly positron emission 
tomography and blood oxygen level-dependent (BOLD)-based functional magnetic 
resonance imaging (fMRI)) suggest that both mania and depression are associated with 
alterations in the rates of substrate oxidation by the brain (Caligiuri et al., 2003; Goodwin et 
al., 1997; Kennedy et al., 1997). Other methods such as 31P magnetic resonance spectroscopy 
(MRS) have provided evidence for dysfunction at the level of brain cells intermediary 
metabolism (Deicken et al., 1995; Kato et al., 1993, 1998; Kato & Kato, 2000). Since cerebral 
oxygen consumption and ATP synthesis are both tightly coupled to TCA cycle activity, such 
changes likely represent significant changes in cellular TCA cycle flux. 
The therapeutic effects of Li+ may be related to modifications of cerebral intermediary 
metabolic rates. Therefore, we studied the effect of Li+ on TCA cycle flux from exogenous 
glucose in human neuroblastoma SH-SY5Y cells, a neuronal model (Biedler et al, 1973). 
Also, in light of studies suggesting that lactate may be an important neuronal oxidative 
substrate (Bouzier-Sore et al., 2003; Pellerin & Magistretti, 2004), the effect of Li+ on 
competition between exogenous lactate and glucose for TCA cycle oxidation in these cells 
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was also investigated. Modifications in the contribution of glucose and lactate to pyruvate 
and acetyl-CoA production could significantly alter the energy status of neuronal cells. 
Finally, the effect of Li+ on the metabolism of glucose in primary cultures of cortical neurons 
and glial cells was also addressed. 
3.1.1 Effects of Li+ on the intermediary metabolism of SH-SY5Y cells 
The effects of Li+ on glucose and lactate metabolism in human neuroblastoma SH-SY5Y cells 
were evaluated by 13C NMR isotopomer analysis, a powerful technique to study metabolic 
intermediary metabolism. Briefly, 13C-labelled substrates ([U-13C]glucose alone or a mixture 
of [U-13C]glucose and [3-13C]lactate) were used and allowed to be metabolised by the cells. 
Their fate was then deduced by 13C NMR analysis of metabolite isotopomer distributions. 
Relative pathways feeding the TCA cycle were estimated from the relative areas of 
glutamate C2, C3 and C4 multiplets in the 13C NMR spectra using the computer program 
tcaCALC (Malloy et al., 1988; Sherry et al., 2004). Figure 7 shows representative 1H-
decoupled 13C NMR spectra of SH-SY5Y cell extracts obtained under control conditions 
(absence of Li+) after incubation for 24 h with [U-13C]glucose (Figure 7A) or a mixture of [U-
13C]glucose plus [3-13C]lactate (Figure 7B). 
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Fig. 7. Representative 1H-decoupled 13C NMR spectra (125.7 MHz) from SH-SY5Y cell 
extracts obtained after incubating the cells for 24 h in Krebs-Ringer Bicarbonate (KRB) 
medium (in mmol L-1: NaCl 119, KCl 4.7, MgSO4 1.2, KH2PO4 1.2, CaCl2 1.3, NaHCO3 24, pH 
7.3) supplemented with 5 mmol L-1 [U-13C]glucose (A) or a mixture of 5 mmol L-1 [U-
13C]glucose and 5 mmol L-1 [3-13C]lactate (B), in the absence of Li+ (control) (Fonseca et al., 
2005). Carbon 2, 3 and 4 resonances of glutamate (Glu) and carbon 3 resonance of lactate 
(Lac) are expanded and assigned as follows: Q - quartet; T - triplet; D - doublet; D12 - doublet 
due to the coupling constant between carbons 1 and 2 (J12) ~ 52 Hz; D23 - doublet due to J23 ~ 
34 Hz; D34 - doublet due to J34 ~ 34 Hz; D45 - doublet due to J45 ~ 52 Hz; S - singlet. 
Resonance assignments: a – glucose C1 ; b – glucose C1 ; c – lactate C2; d – dioxane 
(reference, 67.4 ppm); e – glutamate C2; f – citrate C2,C4; g – malate C3; h – succinate C2,C2’; 
i – glutamate C4; j – glutamate C3; k – lactate C3. 
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13C-incorporation was mainly observed on glutamate and lactate resonances. As for many 
other tissues, glutamate was the most abundant 13C-enriched metabolite at the level of TCA 
cycle intermediates. The complex 13C-13C splitting patterns, expanded in Figure 7 for C4, C3 
and C2 glutamate resonances, reveal the presence of different groups of this metabolite 
isotopomers as a result of glutamate labelling in different positions. The areas of the 
glutamate C2, C3 and C4 resonances in the spectra were calculated and the results 
introduced in tcaCALC program in order to obtain the following relative metabolic 
parameters: lac123 (the fraction of acetyl-CoA derived from the oxidation of [U-13C]pyruvate), 
lac3 (fraction of acetyl-CoA derived from the oxidation of [3-13C]pyruvate, via pyruvate 
dehydrogenase (PDH), when applicable), fat0 (the fraction of acetyl-CoA derived from 
unlabelled acyl sources) and y (anaplerotic flux from all sources). Further details about this 
method can be found in Fonseca et al., 2005. For the neuroblastoma SH-SY5Y cells, the 
metabolic model shown in Figure 8 was the one that provided the best fit between the 
glutamate isotopomer information and metabolic flux parameters as defined by the Monte 
Carlo and other statistical analyses of tcaCALC.   
F1
F2
Succ-CoA
Lactate
Glucose
Citrate
Acetyl-CoA
Fumarate
Pyruvate
Glutamate
Anaplerotic substrates
OAA
F3
F6 (y)
F4 (citrate synthase)
Unlabelled acyl sources
F5 (fat0)
-Ketoglutarate
Malate
(lac123; lac3)
Aspartate
 
Fig. 8. Metabolic model for glucose and lactate metabolism in SH-SY5Y cells, based on 
tcaCALC best fitting solutions (Fonseca et al., 2005). The best fit was achieved with the 
parameter set of lac123, y and fat0. Note that y represents total flux from all anaplerotic 
pathways. Inclusion of carboxylation of labelled pyruvate and/or pyruvate cycling fluxes to 
the model did not significantly improve the fit; hence, these parameters were excluded . 
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Absolute TCA cycle fluxes were calculated using the following equations: 
 Absolute PDH flux (F3) = Total glucose utilisation (F1) – Net lactate production (F2) (4) 
 Absolute citrate synthase flux (F4) = F3/lac123  (5) 
 Absolute endogenous acyl oxidation flux (F5) = fat0 × F4  (6) 
 Absolute endogenous anaplerotic flux (F6) = y × F4  (7) 
Extracellular glucose and lactate concentrations along the experimental period and, hence, 
glucose consumption (F1) and lactate production (F2) rates were calculated using an 
enzymatic method coupled to the increase in NADH absorption at 340 nm. Table 2 
summarises the absolute metabolic fluxes for SH-SY5Y cells incubated in the presence of 5 
mmol L-1 [U-13C]glucose and the effects of 1 and 15 mmol L-1 Li+ on these fluxes. 
 
Absolute metabolic fluxes 
(mol h-1 mg-1 protein) Control 1 mmol L-1 Li+ 15 mmol L-1 Li+ 
Glucose consumption (F1) 0.877  0.362 (n=6) 0.540  0.170 (n=6) 0.411  0.107 * 
(n=5) 
Lactate production (F2) 0.268  0.086 (n=6) 0.275  0.047 (n=6) 0.267  0.064 (n=6) 
Pyruvate dehydrogenase 
(F3) 
0.609  0.302 (n=6) 0.216  0.076 * 
(n=5) 
0.098  0.043 ** 
(n=4) 
Citrate synthase (F4) 0.666  0.331 (n=3) 0.246  0.087 ** 
(n=3) 
0.108  0.047 ** 
(n=3) 
Endogenous acyl oxidation 
(F5) 
0.057  0.029 (n=3) 0.030  0.011 * 
(n=3) 
0.009  0.004 ** 
(n=3) 
Endogenous anaplerosis (F6 ) 0.091  0.047 (n=3) 0.025  0.012 ** 
(n=3) 
0.011  0.006 ** 
(n=3) 
Table 2. Absolute fluxes in SH-SY5Y cells incubated for 24 h at 37 ºC in KRB medium 
containing 5 mmol L-1 [U-13C]glucose, in the absence (control) and presence of 1 or 15 mmol 
L-1 Li+ (Fonseca et al., 2005). Values are means  SD for the number (n) of experiments 
indicated in parenthesis. Glucose consumption rates were multiplied by 2 to express 
consumption in triose units. * and **: p < 0.05 and p < 0.01 relative to control, respectively. 
SH-SY5Y cells have a relatively simple metabolic network featuring a single pyruvate pool 
and no cycling between pyruvate and oxaloacetate (Figure 8). The presence of 1 or 15 mmol 
L-1 Li+ did not alter this optimal set of flux parameters. Under control conditions, TCA cycle 
oxidation accounted for about two-thirds of glucose consumption while the remaining third 
was converted to lactate. With Li+, glucose conversion into pyruvate decreased, which is 
consistent with an inhibition of glycolytic flux, as already reported in literature (Kajda et al., 
1979; Kajda & Birch, 1981; Nordenberg et al., 1982; Zager & Ames III, 1988). This study 
indicates that despite the decrease in glucose consumption by Li+, lactate production rates 
were constant, which is consistent with an unchanged intracellular redox state. However, 
the fraction of glucose consumed by TCA cycle oxidation (given by the absolute PDH flux, 
F3) was significantly reduced by Li+, and this was coupled with reductions in citrate 
synthase and endogenous anaplerotic absolute fluxes, although no significant changes in the 
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relative anaplerotic flux (y) were detected in the presence of Li+. This suggests a direct 
inhibitory effect of Li+ on TCA cycle flux. Possible inhibition sites of the TCA cycle by Li+ 
could include aconitase (Abreu & Abreu, 1973). 13C NMR spectra revealed a tendency for 
higher levels of 13C-enriched citrate in the presence of Li+, which is consistent with 
accumulation of citrate as a result of decreased aconitase activity. Moreover, increased 
citrate levels would inhibit key regulatory glycolytic enzymes such as phosphofructokinase 
thus contributing to the reduction in glucose conversion into pyruvate. 
To determine if Li+ has an effect on the competition between glucose and lactate oxidation 
when both substrates are available, the contribution of exogenous 5 mmol L-1 [U-13C]glucose 
and 5 mmol L-1 [3-13C]lactate to the TCA cycle acetyl-CoA pool was quantified by 13C-
isotopomer analysis in the absence and presence of Li+ (Figure 7B). Both initial glucose and 
lactate concentrations were higher than the apparent Km for glucose and lactate transporters, 
1.16 mmol L-1 (Lust et al., 1975) and 1 mmol L-1 (Dringen et al., 1995), respectively; therefore, 
transport was not expected to be rate limiting for either substrate. Relative fluxes 
corresponding to the fraction of acetyl-CoA derived from [U-13C]glucose (lac123), [3-
13C]lactate (lac3), and unlabelled endogenous sources (fat0) are shown in Table 3. 
 
Relative Flux Parameter Control 1 mmol L-1 Li+ 15 mmol L-1 Li+ 
Acetyl-CoA from [U-13C]glucose 
(lac123) 
0.26  0.03 
(n=3) 
0.26  0.03 
(n=3) 
0.26  0.03 
(n=3) 
Acetyl-CoA from [3-13C]lactate (lac3) 
0.62  0.03 
(n=3) 
0.63  0.03 
(n=3) 
0.65  0.03 
(n=3) 
Acetyl-CoA from endogenous sources 
(fat0) 
0.12  0.01 
(n=3) 
0.12  0.03 
(n=3) 
0.10  0.03 
(n=3) 
Endogenous anaplerotic flux (y) 
0.20  0.02 
(n=3) 
0.19  0.02 
(n=3) 
0.15  0.02 * 
(n=3) 
Table 3. Relative metabolic fluxes for SH-SY5Y cells incubated for 24 h at 37 ºC in KRB 
medium containing a mixture of 5 mmol L-1 [U-13C]glucose and 5 mmol L-1 [3-13C]lactate, in 
the absence (control) and presence of 1 or 15 mmol L-1 Li+ (Fonseca et al., 2005). Values are 
average  SD for the number (n) of experiments indicated in parentheses. All fluxes are 
relative to a citrate synthase flux of 1.0 . * p < 0.05, relative to control. 
In control cells, over 60% of the acetyl-CoA was derived from [3-13C]lactate, more than twice 
the contribution from [U-13C]glucose, demonstrating that exogenous lactate is highly 
preferred over glucose for TCA cycle oxidation under these conditions. The presence of 
either 1 or 15 mmol L-1 Li+ did not alter the relative utilisation of exogenous lactate and 
glucose. However, 15 mmol L-1 Li+ resulted in a small but significant reduction in 
anaplerotic flux from endogenous sources. 
3.1.2 Li+ effects on the metabolic balances in cortical astrocytes and neurons 
The metabolic balance between glucose or acetate consumption and lactate production by 
primary cultures of rat cortical astrocytes and neurons incubated with a mixture of 5 mmol 
L-1 glucose and 5 mmol L-1 acetate or with 1 mmol L-1 glucose, respectively, in the absence 
(control) and presence of 1 or 15 mmol L-1 Li+, was evaluated by classical enzymatic assays. 
Table 4 shows the glucose or acetate consumption as well as lactate production rates 
www.intechopen.com
 Li+ in Bipolar Disorder – Possible Mechanisms of Its Pharmacological Mode of Action 
 
73 
calculated for cortical astrocytes and neurons, in the absence (control) and presence of two 
Li+ concentrations. 
 
Cell type 
Metabolic rates 
(mmol L-1 h-1 mg-1) 
Control 1 mmol L-1 Li+ 15 mmol L-1 Li+ 
Astrocytes 
Glucose consumption 3.19 ± 0.19 (n=5) 2.83 ± 0.27 (n=7)
3.46 ± 0.33   
(n=5) 
Acetate consumption 1.37 ± 0.67 (n=5) 1.11 ± 0.11 (n=5)
1.24 ± 0.52   
(n=4) 
Lactate production 4.02 ± 0.12 (n=5) 3.94 ± 0.14 (n=7)
4.48 ± 0.35   
(n=6) 
Neurons 
Glucose consumption 2.50 ± 0.07 (n=6) 2.34 ± 0.11 (n=6)
2.22 ± 0.10 * 
(n=6) 
Lactate production 0.43 ± 0.08 (n=5) 0.48 ± 0.10 (n=5)
0.37 ± 0.04   
(n=5) 
Table 4. Glucose consumption and lactate production rates by cortical astrocytes or neurons 
incubated in the absence (control) and presence of 1 or 15 mmol L-1 Li+. Acetate 
consumption rates by astrocytes under control and Li+ conditions are also shown. 
Astrocytes were incubated in KRB medium containing a mixture of 5 mmol L-1 glucose and 
5 mmol L-1 acetate, while neurons were incubated with 1 mmol L-1 glucose. Glucose and 
acetate consumption as well as lactate production were defined as the difference between 
the extracellular concentrations at the different time points (t) and the initial concentrations 
(at t = 0 h), i.e., ([glucose]t - [glucose]t=0h), ([acetate]t - [acetate]t=0h) and ([lactate]t - 
[lactate]t=0h), respectively (Fonseca et al., 2009). Values are means ± SEM for the number (n) 
of experiments indicated in parentheses. * p < 0.05 relative to control. 
As expected, neurons showed a preferential oxidative metabolism with a relatively modest 
lactate production, since only 9 % of the glucose consumed was converted into lactate, while 
91 % was oxidised in the neuronal TCA cycle. In contrast, astrocytes were found to be more 
glycolytic as approximately 63 % of the glucose consumed by astrocytes was converted into 
lactate, while only 37 % was oxidised in the astrocytic TCA cycle (Hassel et al., 1995). Our 
results revealed that 15 mmol L-1 Li+ caused a statistically significant decrease in glucose 
uptake by neurons but no apparent effects in glucose or acetate uptake by astrocytes. The 
decrease in neuronal glucose uptake in the presence of Li+, consistent with an inhibition of 
the glycolytic flux, was not paralleled by a concomitant significant change in lactate 
production, indicating that the decreased glucose consumption reflects a net decrease in 
glucose oxidation and TCA cycle activity (Fonseca et al., 2009). The ability of Li+ to decrease 
glycolytic and TCA cycle fluxes is in agreement with the results obtained for SH-SY5Y cells 
(Fonseca et al., 2005) and other data in the literature (Abreu & Abreu, 1973; Kajda & Birch, 
1981; Nordenberg et al., 1982).  
In summary, the present study provides evidence that both TCA cycle and glycolysis are 
targets for Li+ action in the neuroblastoma SH-SY5Y cell line and the inhibition of the TCA 
cycle, and hence of cell energy production, observed for therapeutic concentration of Li+ (1 
mmol L-1) may constitute one hypothesis for the mechanism by which Li+ exerts its 
antimanic effect. However, in cortical neurons only the highest Li+ concentration (15 mmol 
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L-1) was able to decrease neuronal glucose consumption and TCA cycle activity. Although 
Li+ has a narrow therapeutic range—it is toxic in vivo for plasma concentrations higher than 
2 mmol L-1 —the 15 mmol L-1 Li+ concentration was found to be nontoxic for both neurons 
and astrocytes under our experimental conditions (data not shown). Furthermore, Li+ 
concentrations achieved in the intercellular space are uncertain, but are expected to reach 
much higher levels than in plasma. Despite these limitations, the results presented here 
strengthen the importance of cell energetic metabolism as a target for Li+ action, an area of 
study that has been underestimated and poorly reported in the literature. 
3.2 Li+ effects on glutamatergic and GABAergic neurotransmissions in adult rat brain 
and cultured brain cells, as revealed by 13C NMR 
Besides its metabolic effects, Li+ was proposed to alter the balance between excitatory and 
inhibitory neurotransmitter systems, thus modulating glutamatergic and GABAergic 
neurotransmission (Antonelli et al., 2000; Brambilla et al., 2003; Gottesfeld, 1976; Jope et al. 
1989; Marcus et al., 1986; O’Donnell et al., 2003; Otero Losada & Rubio, 1986; Petty, 1995; 
Rubio & Otero Losada, 1986; Shiah & Yatham, 1998) and facilitating in this way, mood 
recovery and stabilisation in Li+-treated bipolar patients. However, the effects of Li+ have 
been studied using different experimental models and protocols that have often yielded 
different or even contradictory results. In this study, we have used the 13C NMR technique 
to investigate the effects of Li+ on the metabolism of glutamate, glutamine and GABA in the 
adult intact rodent brain and in primary cultures of cortical neurons and astrocytes. This 
technique has been used successfully to study cerebral metabolic compartmentation and the 
glutamate-glutamine cycle as the basis of glutamatergic and GABAergic neurotransmissions 
(Rodrigues & Cerdán, 2005). 
Adult male rats receiving a single dose of Li+ intraperitoneally (7 mmol kg-1), or saline 
(control), were infused with [1-13C]glucose or [2-13C]acetate. Glucose is considered a 
universal substrate for neurons and glial cells, although it is thought to be metabolized more 
in the neuronal TCA cycle; in contrast, acetate is considered a glial substrate because it is 
selectively taken up by astrocytes by a specialized transport system, which is absent or less 
active in neurons (Waniewski & Martin, 1998; Sonnewald & Kondziella, 2003). Brain extracts 
were prepared 3 h after Li+ injection and analysed by 13C NMR.  The mean Li+ 
concentrations in brain and plasma achieved 3 h after i.p. Li+ injection were 1.5  0.4 mmol 
kg-1 tissue wet-weight (n=5) and 1.3  0.5 mmol L-1 (n=7), respectively. Figure 9 summarizes 
the results obtained from the quantitative analysis of  13C incorporation in the aliphatic 
carbons of glutamate, glutamine and GABA from the brain of control and Li+-treated 
animals. 
With [1-13C]glucose as substrate, Li+ decreased the incorporation of 13C in the observable 
carbons of glutamate, glutamine and GABA, with statistical significance for the C4 and C3 
carbons of glutamate and GABA, respectively. Apparently Li+ administration did not 
change the 13C labelling of these metabolites after [2-13C]acetate infusions. Because [1-
13C]glucose is believed to be a universal substrate for neurons and glial cells and [2-
13C]acetate is known to be mainly a glial substrate, our results suggest that the inhibition 
observed in vivo must occur primarily in the neuronal compartment, at an upstream level of 
the glutamate-glutamine-GABA cycles. Glucose consumption through glycolysis and the 
TCA cycle could be a possible target for this upstream Li+ action (Fonseca et al., 2005, 2009; 
www.intechopen.com
 Li+ in Bipolar Disorder – Possible Mechanisms of Its Pharmacological Mode of Action 
 
75 
Nordenberg et al., 1982; Plenge, 1976; Zager & Ames, 1988;). Li+ significantly increased the 
glutamate C3/GABA C3 labelling ratio (p < 0.01), suggesting that Li+ may affect the 
synthesis of GABA from its direct precursor glutamate in the neuronal compartment, in vivo, 
possibly through the inhibition of glutamate decarboxylase activity (Fonseca et al., 2009). 
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(A) (B) 
Fig. 9. Graphical representation of 13C NMR signal areas of the metabolites glutamate, 
glutamine and GABA, as observed in the 13C NMR spectra obtained form rat brain extracts 
prepared after saline (control) and Li+ administration, and infusion with [1-13C]glucose (n=3 
for both saline- and Li+-treated rats) (A) or [2-13C]acetate (n=4 for saline- and n=5 for Li+-
treated rats) (B) (Fonseca et al., 2009). Tissue wet weight and appropriate correction factor 
for nuclear Overhauser enhancement and signal saturation were taken into account. Values 
are means ± SEM for the indicated number of experiments. * p < 0.05 relative to control. Glu 
- glutamate; Gln – glutamine. 
To investigate this mechanism in more detail, we used primary cultures of cortical neurons 
and astrocytes. The 13C NMR spectra of extracts obtained from the cellular layers of 
astrocyte cultures after incubation with 5 mmol L-1 [2-13C]acetate, or neuron cultures 
incubated with 1 mmol L-1 [U-13C]glucose, showed an extensive incorporation of 13C from 
the 13C-labeled substrates in the C2, C3, and C4 carbons of glutamate and glutamine, C2 and 
C3 of aspartate (and C2, C3, and C4 of GABA and C3 of lactate for neurons). Table 5 shows 
the relative ratios between the areas of the C4 and C3 carbon resonances of glutamine and 
glutamate obtained from the 13C NMR spectra of astrocyte extracts, as well as the ratios 
between the areas of the C2, C3, and C4 carbon resonances of glutamate and the C4, C3 and 
C2 carbon resonances of GABA, respectively, obtained from the 13C NMR spectra of neuron 
extracts. The reason for selecting and comparing the areas of these specific carbon 
resonances of glutamate and GABA was based on the well-known metabolic fate of 13C 
labelling from 13C-labeled substrates because the order of 13C-labeled carbons in glutamate is 
reversed in GABA (e.g., the labels in (2(4)-13C) glutamate end up subsequently in (4(2)-13C) 
GABA) (Sonnewald & Kondziella, 2003). 
When 15 mmol L-1 was used, an increase in glutamate C2/GABA C4 (p<0.05), glutamate 
C3/GABA C3 and glutamate C4/GABA C2 13C labelling ratios was observed, suggesting 
that Li+ may decrease GABA synthesis from glutamate, its direct precursor in cortical 
GABAergic neurons. These findings reflect a direct inhibitory effect of Li+ on glutamate 
decarboxylase activity and are in agreement with the in vivo studies, where a more 
pronounced reduction in 13C labelling of GABA relative to glutamate was observed. Indeed, 
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previous studies have reported Li+-induced inhibitory effects on glutamate decarboxylase 
(Otero Losada & Rubio, 1986; Rubio & Otero Losada, 1986). 
 
Cell type Area ratio Control 1 mM Li+ 15 mM Li+ 
Astrocytes 
Gln C4/Glu C4 0.76  0.37 0.58  0.29 0.32  0.17 
Gln C3/Glu C3 1.12  0.54 1.13  0.43 0.64  0.29 
Neurons 
Glu C2/GABA C4 1.60  0.15 1.64  0.21 2.95  0.45 * 
Glu C3/GABA C3 2.12  0.26 1.69  0.29 3.64  1.06 
Glu C4/GABA C2 2.04  0.19 1.99  0.35 3.12  0.79 
Table 5. Relative ratios between the areas of the C4 and C3 carbon resonances of glutamine 
(Gln) and glutamate (Glu), as well as between the areas of the C2, C3 and C4 carbon 
resonances of GABA and the C4, C3 and C2 carbons of Glu, respectively, calculated from the 
13C NMR spectra of astrocyte or neuron extracts. Cells were incubated for 24 h at 37 ºC in the 
absence (control) and presence of 1 and 15 mmol L-1 Li+, in a modified KRB medium 
containing 5 mM [2-13C]acetate (astrocytes) or 1 mM [U-13C]glucose (neurons) (Fonseca et 
al., 2009). Values are means  SEM of 3 independent experiments.  * p < 0.05, relative to the 
control.  
In summary, Li+ was found to decrease the incorporation of 13C labelling into GABA 
carbons from its precursor glutamate in neurons, both ex vivo and in vivo, probably 
through the inhibition of glutamate decarboxylase. These inhibitory effects, together with 
those detected in glucose consumption and TCA cycle activity of neurons, configure a 
complex mechanism of Li+ action involving inhibitory actions at multiple sites. The results 
presented here may provide a new insight into the basis of the metabolic effects of Li+ on 
brain metabolism involving the modulation of the main excitatory and inhibitory systems, 
which may facilitate mood recovery and stabilization in bipolar patients. 
4. Effect of mood stabilizers on the regulation of cyclic AMP levels by 
dopaminergic and  -adrenergic receptors 
4.1 Intracellular lithium and cyclic AMP levels are mutually regulated in neuronal cells 
Recent research has been focused on how Li+ changes the activity of cellular signal 
transduction systems, in particular those involving AC. It has been suggested that cAMP 
levels are abnormal in bipolar patients and are regulated by mood stabilizing agents. So, it is 
important to know whether this second messenger regulates Li+ transport into neuronal 
cells and determine the effect of Li+ on the homeostasis of intracellular cAMP levels, which 
depends on the AC activity. Thus, the effect of intracellular cAMP on Li+ uptake, at 
therapeutic plasma concentrations, in SH-SY5Y human neuroblastoma cells and in primary 
cultures of rat cortical and hippocampal neurons was studied. The cells were stimulated 
with forskolin, a direct activator of the catalytic subunit of AC, or with the cAMP analogue 
dibutyryl-cAMP, to increase intracellular cAMP levels. Intracellular Li+ was quantified by 
AA spectrophotometry and cAMP levels were determined under basal and forskolin 
stimulated-conditions, and in the presence and absence of Li+, through a radioactive assay 
using [8-3H]cAMP. 
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The kinetics of Li+ influx and Li+ uptake by SH-SY5Y cells and cortical and hippocampal 
neurons, in the presence and absence of forskolin, was studied and the results presented in 
Figure 10 details of experimental procedure in figure legend). 
It was observed (Figure 10 A,B) that under forskolin stimulation both the Li+ influx rate 
constant ki, [0.028  0.005 min-1 (ctrl) and 0.041  0.005 min-1 (fsk); p< 0.05] and the Li+ 
accumulation in SH-SY5Y cells were increased (27.6  1.8 nmoL mL-1  vs the control value 
17.9  1.7 nmoL mL-1; p< 0.01). Dibutyryl-cAMP also increased Li+ uptake confirming that 
these effects were due to an increase in intracellular cAMP and not to a non-specific effect of 
forskolin [126.9  11.6  % for forskolin (p< 0.01 relative to ctr) and 142.6  13.9  % for db-
cAMP (p< 0.001, relative to ctr) and not significantly different between them]. Identical 
results were obtained with cortical [133.5  5.9  % for forskolin (p< 0.01) and 154.0  9.3 % 
for db-cAMP (p< 0.001)] and hippocampal neurons [133.3  11.9 % for forskolin (p< 0.05) 
and 141.4  6.9 %; for db-cAMP (p< 0.05)] (Figure 10 C,D).  To obtain information about the 
transport pathways responsible for Li+ uptake under resting and forskolin stimulated 
conditions, experiments were carried out using inhibitors of specific transporters at SH-
SY5Y cells membrane (details are in the legend of the figure) and the intracellular Ca2+ 
chelator BAPTA. The graphs of Figure 11 show the data obtained.  
 
 
 
(A) (B) (C) (D) 
 
 
Fig. 10. Kinetics of Li+ influx in SH-SY5Y cells, in the absence (○) (ctrl) and in the presence 
(●) of forskolin (fsk) (A). The cells were pre-incubated with RO-201724, the cAMP 
phosphodiesterase inhibitor (Miles et al., 1987), (25 mol L-1), for 15 min, and then with fsk 
(10 mol L-1), for 15 min. LiCl at 1 mmol L-1 concentration was then added to the medium 
and at 5, 15, 30, 45, 60 or 120 min; the amount of Li+ taken up by cells was measured by AA 
spectrophotometry.  The rate constants obtained for Li+ influx were 0.028  0.005 min-1 (ctrl) 
and 0.041  0.005 min-1 (fsk) (p< 0.05). Values are means  SEM of 4-20 independent 
experiments. Li+ uptake by SH-SY 5Y cells (B), by cortical (C) or hippocampal neurons (D), 
pre-treated or not (ctrl) with fsk (10 µmol L-1; 15 min) or db-cAMP (500 µmol L-1; 30 min) 
after pre-incubating the cells with RO-201724 (25 mol L-1, 15 min), and before incubation 
with 1 mmol L-1 Li+, for 30 min. The total amount of intracellular Li+ was measured by AA 
spectrophotometry, as described in (Montezinho et al., 2004). Data are presented as a 
percentage of intracellular Li+ content relative to the control. Values are means  SEM., for 
the indicated number of independent experiments. *, p< 0.05;  **, p< 0.01; ***, p< 0.001, 
significantly different from control; ns= not significant (Montezinho et al., 2004). 
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Fig. 11. Pharmacological characterization of Li+ uptake by SH-SY5Y cells under resting 
conditions (A) and after  fsk stimulation  (B) and (C). The cells were pre-treated with RO-
201274 (25 mol L-1, 15 min), and then with the following drugs, at different concentrations 
and pre-incubation times: TTX (1 mol L-1; 5 min), -Conotoxin GVIA (-CgTx GVIA;0.5 
mol L-1; 30 min), KT-5720 (10 mol L-1; 10 min), BAPTA-AM (10 µmol L-1; 30 min), KB-
R7943 (20  µmol L-1; 5 min) and nifendipine (Nif) (1 µmol L-1; 5 min), to study the 
contribution of voltage-sensitive sodium channels (VSSC), N-type voltage-sensitive calcium 
channels (VSCC), PKA, [Ca2+]i, Na+/Ca2+ exchanger and L-type VSCC, respectively, for Li+ 
uptake by the cells under resting conditions  (A). To study the contribution  of all these 
transport pathways  to the fsk-induced Li+ uptake, after exposure to the drugs, in the same 
concentrations and pre-incubation times, the cells were incubated with fsk (10 µmol L-1), for 
15 min (B, C). Then, in all cases, 1 mmol L-1 LiCl was added to the medium and after 30 min 
the amount of Li+ taken up by the cells was measured by AA spectrophotometry. Total 
intracellular Li+ content is presented as a percentage relative to the control. Values are 
means  SEM, for the indicated number of independent experiments. ***, p< 0.01 and **, p< 
0.01, significantly different from control, respectively, under resting and fsk stimulated 
conditions; +, p< 0.05; ++, p< 0.01; +++, p< 0.001, significantly different from fsk stimulation in 
the absence of any of these drugs (Montezinho et al., 2004). 
Under resting conditions, the inhibitor of the Na+/Ca2+ exchanger, KB-R7943, reduced the 
influx of Li+ and completely inhibited the effect of forskolin on the increase of Li+ uptake, 
although this effect was attenuated also by KT-5720 (protein kinase A (PKA) inhibitor), -
Conotoxin GVIA (N-type voltage-sensitive calcium channels (VSCC) inhibitor) or BAPTA 
(Ca2+ chelator). This indicates that the Na+/Ca2+ exchanger is the principal responsible for 
Li+ influx into SH-SY5Y cells in these conditions. 
The involvement of intracellular Ca2+ concentration ([Ca2+]i) in Li+ uptake, under resting and 
after forskolin stimulation, was investigated in the presence of different  inhibitors of 
pathways which contribute to [Ca2+]i homeostasis by measuring intracellular free Ca2+ levels 
using fluorescence spectroscopy (Figure 12).  
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Fig. 12. Pharmacological characterization of the pathways for [Ca2+]i homeostasis in SH-
SY5Y cells under resting conditions (A) and after stimulation with fsk (B). Cells were pre-
treated with RO-201724 (25 µmol L-1,15 min), and then with -CgTx GVIA (0.5 µmol L-1; 30 
min), Nif (1 µmol L-1; 5 min), KB-R7943 (20 µmol L-1;  5 min), KT-5720 (10 µmol L-1; 10 min) 
or TTX (1 µmol L-1; 5 min), to test the contribution of N- and L-type VSCC, Na+/Ca2+ 
exchanger, PKA and VSSC, respectively, to the maintenance of the [Ca2+]i. The effect of the 
Ca2+ chelator, BAPTA, was also determined by pre-incubating the cells with 10 µmol L-1 
BAPTA-AM, for 30 min. The cells were stimulated or not with 10 µmol L-1 fsk, for 15 min, 
and the [Ca2+]i was determined by fluorescence spectroscopy using fura-2. Values are means 
 SEM, for the indicated number of independent experiments. **, p< 0.01, significantly 
different from control; +, p< 0.05; ++, p< 0.01, significantly different from fsk stimulation in 
the absence of any drug (Montezinho et al., 2004). 
It was observed that under resting conditions only KB-R7943 increased [Ca2+]i in SH-SY5Y 
cells, confirming the role of the Na+/Ca2+ exchanger on intracellular homeostasis (Figure 
12A). Intracellular Ca2+ chelation (with BAPTA), or inhibition of N-type VSCC (-CgTx 
GVIA), or inhibition of cAMP-dependent protein kinase A (KT-5720) abolished the effect of 
forskolin on Li+ uptake (Figure 12B). All these conditions decrease free [Ca2+]i, as 
demonstrated by the quantification of Ca2+ levels, demonstrating the involvement of Ca2+ on 
forskolin-induced Li+ uptake. 
SH-SY5Y cells were exposed to 1 mmol L-1 Li+ for different periods of time to check its effect 
on cAMP levels. Figure 13A shows that after 24 h to Li+ exposure, basal cAMP levels 
increased, which can be explained by the inhibition of Gi, the G proteins most active in basal 
conditions. Pre-incubation of the cells with 1 mmol L-1 Li+, during 1, 24 or 48 h, decreased 
cAMP production in response to forskolin (Figure 13B) which may be due to inhibition of 
AC activity as a result from Li+/Mg2+ competition.  
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Fig. 13. Effects of Li+ on cAMP production by SH-SY5Y cells. (A) Cells were pre-treated with 
RO-201724 (25 µmol L-1, 15 min), and then incubated or not (ctrl) with 1 mmol L-1 Li+, for the 
indicated periods of time. (B) Where indicated, the cells were stimulated with 10 µmol L-1 
fsk, for 15 min, after treatment with Li+. The cAMP levels were measured as described 
(Montezinho et al., 2004). (C) MTT biochemical assay with SH-SY5Y cells treated with LiCl 
(0, 0.5, 1, 5 and 15 mmol L-1), during a period of 48h. Data are presented as a percentage 
relative to the control. Values are means  SEM, for the indicated number of independent 
experiments. *, p< 0.05; ***, p< 0.001, significantly different from the control. ++, p< 0.01, 
significantly different from fsk stimulation in the absence of Li+ (Montezinho et al., 2004). 
These data indicate that forskolin AC activation increases Li+ influx in the three cellular 
models, an effect mediated by PKA and due to changes in [Ca2+]i. The intracellular cAMP 
accumulation increases [Ca2+]i, due to its entry through N-type VSCC, thus activating 
Na+/Ca2+ exchanger allowing the increase of Li+ influx, by substituting Na+, in exchange 
with Ca2+ extrusion (Deval et al., 2002; Fonseca et al., 2004; Montezinho et al., 2004). 
Overall, these results demonstrate that intracellular cAMP levels regulate Li+ uptake in a 
Ca2+-dependent manner, and Li+ plays an important role in the homeostasis of this second 
messenger in neuronal cells. This is relevant data to understand the mechanism of action of 
Li+, taking into account several aspects already mentioned in the literature such as: bipolar 
disorder is associated with deregulation in AC mediated signal transduction processes, 
which are affected by Li+ (Berns & Nemeroff, 2003; Brunello & Tascedda, 2003; Manji & 
Lenox, 2000a, 2000b; Manji et al., 2001), and with increased [Ca2+]i (Hough et al., 1999) 
pointing to an interaction between intracellular signalling mechanisms mediated by Ca2+ 
and cAMP (Cooper et al., 1995); bipolar patients with a [Ca2+]i higher than normal respond 
better to Li+ treatment, indicating a possible correlation between Ca2+ levels and Li+ 
response (Ikeda & Kato, 2003). 
4.2 Effect of mood stabilizers on dopamine D2-like receptor-mediated inhibition of 
adenylate cyclase 
Second messenger-mediated pathways represent targets for Li+ action; thus, it is important 
to investigate whether other mood stabilizing agents exert similar effects on the same 
signalling pathways. Bipolar disorder seems to be associated with an enhanced signalling 
activity of the cAMP cascade and most of its events have been implicated in the action of 
www.intechopen.com
 Li+ in Bipolar Disorder – Possible Mechanisms of Its Pharmacological Mode of Action 
 
81 
mood stabilizing drugs, which somehow modulate brain cAMP levels. Therefore, the effects 
of Li+, carbamazepine and valproate on basal and forskolin-evoked cAMP accumulation 
were studied both ex vivo, in cultured cortical neurons,  and in vivo in the rat prefrontal 
cortex using microdialysis in freely moving animals, a technique which detects extracellular 
cAMP levels, thus accurately reflecting intracellular changes in AC activity (Masana et al., 
1991, 1992). It has been demonstrated that a fraction of intracellular cAMP generated by 
activation of AC is extruded into the extracelular fluid in proportion with its accumulation 
in cells. Therefore, the efflux of cAMP can be used to study the cAMP second messenger 
system in intact brains, using in vivo microdialysis (Mørk & Geisler, 1994). Moreover, the 
capacity of dopamine D2-like receptors stimulation, with quinpirole, to block the increase of 
forskolin-stimulated cAMP levels was  measured under control conditions and after 
treatment with the mood stabilizing drugs. The cAMP was quantified using the [8-3H] and 
[125I] radioimmunoassay kits, respectively for the ex vivo and in vivo experiments. 
Figure 14 shows the determination of intracellular cAMP levels in cultured cortical neurons as 
a response to different experimental conditions (protocols are detailed in the figure legend).  
 
Fig. 14. Effects of lithium, valproate and carbamazepine on the intracellular cAMP levels in 
cultured cortical neurons under basal conditions and after stimulation with forskolin or 
quinpirole plus forskolin. Neurons were pre-exposed or not (control) to 1 mmol L-1 lithium, 
0.05 mmol L-1 carbamazepine or 0.5 mmol L-1 valproate, for 48 h. After this period, neurons 
were incubated with Ro-201724 (25 µmol L-1; 15 min) and were then treated or not (basal) 
with forskolin (10 µmol L-1; 15 min), or with forskolin together with quinpirole (10 µmol L-1; 
15 min). In the latter experimental conditions the cells were pre-treated with 10 µmol L-1  
quinpirole for 5 min. The cAMP levels were measured as described (Montezinho et al., 
2007).  The levels of cAMP are presented as percentage relative to the control. Data are 
means  SEM, for the indicated number of independent experiments, performed in 
duplicate. Data were analysed by one-way ANOVA, followed by post-hoc Bonferroni´s test. 
&&&, p< 0.001 compared to control untreated cells; ***, p< 0.01 compared to control forskolin-
stimulated cells (Montezinho et al., 2007).   
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Lithium, carbamazepine or valproate had no effect on the basal cAMP production, but 
partially inhibited forskolin-induced cAMP accumulation (control: 495.8 ± 39.0 %, p < 0.001 
(5× basal value); lithium: 290.1 ± 51.8 %, p< 0.001; carbamazepine: 273.9 ± 13.1 %, p< 0.001; 
valproate: 319.6 ± 23.4 %, p< 0.001). In the presence of quinpirole, the agonist of dopamine 
D2-like receptors, no effect on the basal cAMP accumulation was observed (data not shown), 
but inhibition of forskolin-enhanced cAMP levels occurred in untreated neurons (335.6 ± 
42.8 %, p< 0.001); the activation of dopamine D2-like receptors had no additional effect in 
cortical neurons treated with the mood stabilizers (lithium: 305.2 ± 46.2 %; carbamazepine: 
273.9 ± 13.1 %; valproate: 341.9 ± 24.7 %, p< 0.001).  
Similar experiments were carried out in vivo. Extracellular cAMP levels were determined in 
prefrontal cortex of freely moving rats by microdialysis and the obtained results are shown 
in Figure 15 (detailed experimental conditions are in the legend of this figure). 
 
(A) (B) 
Fig. 15. Effect of local infusion of forskolin (100 µmol L-1) (A) and forskolin (100 µmol L-1) or 
quinpirole (100 µmol L-1) simultaneously with forskolin (100 µmol L-1) (B) in the prefrontal 
cortex of freely moving rats (starting at arrow and maintained during 30 min) on the 
extracellular cAMP levels of (A) control-, vehicle-, lithium-, valproate- or carbamazepine-
treated rats; (B) control rats a) or rats chronically treated with lithium b), carbamazepine c), 
vehicle d) or valproate  e). Baseline levels of cAMP were taken as the average cAMP content in 
the four consecutive samples collected 3 h after the insertion of the probe. Thereafter, the agent 
of interest (100 µmol L-1  forskolin or 100 µmol L-1  quinpirole plus 100 µmol L-1  forskolin) 
dissolved in Ringer solution was infused through the probe, for 60 min, and seven samples 
were then collected. Extracellular cAMP levels in the dialysates were measured by 
radioimmunoassay analysis and expressed as percentage of the basal value. Results are 
expressed as means  SEM, from 4 to 6 independent experiments. The rats were treated or not, 
during three weeks, with therapeutic doses of lithium (n= 6) or carbamazepine (n=6) in the diet, 
whereas others were treated with therapeutic doses of valproate (n= 6) by intraperitoneal 
injections once daily, for three weeks. Control rats (n= 6) received standard diet, whereas 
vehicle rats (n= 4) received intraperitoneal injections with saline solution (NaCl 0.9%) once daily 
during three weeks (Montezinho et al., 2007). Data are analyzed by one-way ANOVA, followed 
by post-hoc Bonferroni´s test. ***, p< 0.001; compared to the cAMP produced 60 min after the 
infusion of forskolin in control rats. +++, p< 0.001; compared to the cAMP produced 60 min after 
the infusion of forskolin in vehicle-treated rats. §§§, p< 0.001; compared to the cAMP produced 
60 min after the infusion of quinpirole plus forskolin in control rats. &&&, p< 0.001, compared to 
the cAMP produced 60 min after the infusion of forskolin in carbamazepine-treated rats.  
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After forskolin infusion in the prefrontal cortex of the rats, for 30 min, the average basal 
cAMP levels (control: 9.68 ± 2.10 fmoL/20 µL; lithium-treated animals: 13.17 ± 1.21 fmoL/20 
µL (p< 0.05 relative to control); carbamazepine-treated rats, 7.82 ± 0.34 fmoL/20 µL (p< 0.01 
relative to control); valproate-treated rats: 10.42 ± 1.06 fmoL/20 µL) increased to 
approximately 647.0 ± 58.3 % and 644.5 ± 68.9 % of the basal values (control and vehicle, 
respectively) whereas in lithium-, carbamazepine- or valproate-treated rats there was a 
statistically significant decrease in the forskolin-stimulated cAMP levels determined after 60 
min of forskolin infusion (lithium: 176.0 ± 11.5 %, p< 0.001; carbamazepine: 383.2 ± 44.9 %, 
p< 0.001; valproate: 310.3 ± 29.1 %, p< 0.001), when compared to the values from control or 
vehicle-treated rats (Figure 15A) 
Forskolin-induced increase in extracellular cAMP  was significantly inhibited in the 
presence of quinpirole, in control and vehicle-treated rats (respectively 187.6 ± 24.6 %, p< 
0.001 and  282.7 ± 34.4, p< 0.001) (Figure 15B a) and d)), as measured 60 min after the 
infusion of the dopamine D2-like receptors agonist. However, in lithium- or valproate-
treated rats no difference occurred in the forskolin-induced increase in extracellular cAMP 
in the absence or presence of the agonist (Figure 15B b) and e)) whereas in carbamazepine-
treated animals an unexpected increase was observed (885.5 ± 152.7 %, p< 0.001) (Figure 
15B c)) after infusion of quinpirole plus forskolin, being the obtained value even higher 
than that observed in control animals under the same conditions (187.6 ± 24.6 %) (Figure 
15B a)) or in carbamazepine-treated rats infused only with forskolin (383.2 ± 44.9 %) 
(Figure 15B c)).  
No statistical significant effect on basal cAMP levels neither under control conditions 
(control rats: 100.4 ± 18.4 %; vehicle-treated rats:  104.0 ± 11.3 %) nor in carbamazepine-
treated animals (114.4 ± 8.9 %) was observed after activation of dopamine D2-like receptors 
(data not shown).   
Taken together, these results indicate that lithium, carbamazepine and valproate, at 
therapeutically relevant concentrations, modulate basal and forskolin evoked cAMP 
production. These drugs had no effect on basal cAMP levels in vitro, but differential effects 
were observed in vivo, in agreement with literature data (Jope,1999a, 1999b; Masana et al., 
1991, 1992; Montezinho et al., 2004; Mørk & Jensen, 2000). The different behaviour with cells 
and in vivo may be due to the lack of afferent projections releasing catecholamines, which 
could be regulated by the chronic in vivo drug infusion (Dziedzicka-Wasylewska et al., 1996; 
Ichikawa & Meltzer, 1999). Direct stimulation of AC with forskolin increased the levels of 
cAMP both in vitro and in vivo, and this effect was significantly inhibited by all three mood 
stabilizers. Activation of dopamine D2‐like receptors partially inhibited the 
forskolin‐induced increase in cAMP in untreated cell cultures, likely due to AC  inhibition 
(Memo et al., 1992), but no further attenuation in cAMP levels was observed in cultured 
cortical neurons treated with the three mood‐stabilizing drugs, suggesting that, in this case, 
there are no additive effects, although these drugs can act through different mechanisms 
(Chen et al., 1996a, 1996b; Gallagher  et al., 2004; Montezinho et al., 2004; Mørk & Jensen, 
2000; Post et al., 1992). 
Similar results were obtained upon chronic in vivo treatment with Li+ and valproate in the 
rat prefrontal cortex. However, in carbamazepine‐treated animals, the activation of 
dopamine D2‐like receptors, surprisingly, enhanced the responsiveness of AC to activation 
by forskolin, possibly due to what is described as super-sensitization of AC, a 
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neuroadaptative mechanism that occurs under prolonged inhibition of this enzyme 
(Johnston CA & Watts, 2003). This may have an important role in tolerance and dependency 
effects generally observed in chronic abuse drugs administration, which are known to 
induce AC sensitization due to the persistent activation of Gi-coupled receptors. The 
molecular mechanisms involved in super-sensitization are not completely clarified, 
however, some studies show that chronic inhibition of PKA induces AC sensitization in 
some cellular systems and that activation of this kinase has the opposite effect (Johnston et 
al., 2002). 
The down-regulation of the basal cAMP levels by chronic carbamazepine treatment could 
therefore underlie the sensitization of the dopamine D2-like receptors in prefrontal cortex in 
vivo. Inhibition of cAMP formation decreases cAMP-dependent PKA activity and inhibits 
subsequent PKA-mediated phosphorylation events. Recent results demonstrated that 
chronic inhibition of PKA induced supersensitization of AC in neuronal cell line and that 
activators of PKA attenuated sensitization. Although inhibition of cAMP and PKA is not 
generally required for the development of super-sensitization of AC, inhibition of PKA may 
contribute to the development of sensitization in select cellular models (Johnston et al., 
2002). 
From these data, it can be speculated that mechanisms such as the sensitization of 
dopamine D2-like receptors due to the chronic inhibition of AC by carbamazepine, 
contribute to the increased relapsed rate observed in patients under monotherapy with 
this drug for 3-4 years (Post et al., 1990), although it is an effective drug in the acute 
treatment of bipolar disorder. 
In conclusion, abnormal function of brain AC and dopamine systems may be implicated in 
bipolar disorder. Chronic treatment with lithium, carbamazepine and valproate affects the 
basal and evoked cAMP levels in a distinct way, both ex vivo and in vivo, resulting in 
differential responses to dopamine D2-like receptors activation, and suggesting that 
additional signalling systems are involved as well.  
4.3 The interaction between dopamine D2-like and -adrenergic receptors in the 
prefrontal cortex is altered by mood stabilizing agents 
Biogenic monoaminergic neurotransmission has been suggested to be involved in bipolar 
disorder as well as in the therapy for this disease. The dopamine D2 receptor is the 
predominant member of the family of D2-like dopamine receptors in the brain (Emilien et 
al., 1999) and the 1-adrenergic receptors are the most abundant members of -adrenergic 
receptors in the cerebral cortex (Rainbow et al., 1984). The effects of the mood stabilizing 
drugs lithium, carbamazepine or valproate on the intracellular signalling mediated by 
receptors coupled to activation and inhibition of AC were investigated. Thus, experiments 
with the dopaminergic and adrenergic systems, particularly on D2-like and -adrenergic 
receptors, respectively positive and negatively coupled to AC, were performed both in 
cultured rat cortical neurons and in prefrontal cortex of freely moving rats, using 
microdialysis (Masana et al., 1991, 1992). 
Isoproterenol and quinpirole were used to stimulate -adrenergic and dopamine D2-like 
receptors, respectively, and cAMP levels inside neurons and in the dialysates were 
determined by a radioimmunoassay using the [8-3H-] and [125I], respectively for the ex vivo 
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and in vivo experiments. Moreover, the cAMP levels produced by the stimulation of -
adrenergic receptors with isoproterenol as well as the ability of the activation of dopamine 
D2-like receptors to block the increase of isoproterenol-evoked cAMP levels were measured 
under control conditions and after the treatment with  mood stabilizing drugs. 
Immunohistochemistry and western blot techniques were used to investigate if 1–
adrenergic and D2 dopaminergic receptors are co-localized in the rat prefrontal cortex and if 
the three drugs have any effect on the levels of these receptors on the membranes of cortical 
neurons. 
The cAMP accumulation in cultured cortical cells is presented (Figure 16), using the 
experimental conditions described in the legend of the figure. 
 
Fig. 16. Effects of lithium, valproate and carbamazepine on the intracellular cAMP levels in 
cortical neurons under basal conditions and after stimulation with isoproterenol or 
quinpirole plus isoproterenol. Neurons were pre-exposed or not (control) to 1 mmol L-1 
lithium, 0.05 mmol L-1 carbamazepine or 0.5 mmol L-1 valproate, for 48 h. After this period, 
neurons were incubated with RO-201724 (25 µmol L-1, 15 min) and were then treated or not 
(basal) with isoproterenol (10 µmol L-1; 15 min), or with isoproterenol together with 
quinpirole (10 µmol L-1; 15 min). In the latter experimental conditions the cells were pre-
treated with 10 µmol L-1  quinpirole for 5 min. The cAMP levels were measured as described 
(Montezinho et al., 2006). The average value of basal cAMP level for all cells tested (101.4 ± 
21.0 nmoL µg-1 protein) was set to 100 %. Data are means  SEM, for the indicated number 
of independent experiments, performed in duplicate. Data were analyzed by one-way 
ANOVA, followed by post-hoc Bonferroni’s test for multiple comparisons. ###, p< 0.001; #, 
p< 0.05 compared to control isoproterenol-treated cells; +, p< 0.05; ++, p< 0.01 compared to 
control quinpirole plus isoproterenol-stimulated cells; &&&, p< 0.001 compared to control of 
untreated cells; *, p< 0.05; **, p< 0.01 compared to neurons pre-exposed to LiCl and 
valproate, respectively (Montezinho et al., 2006). 
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In the ex vivo studies, the average value of 101.4 ± 21.0 nmol µg-1 protein for basal cAMP 
level was set to 100 %. Isoproterenol stimulation produced a cAMP increase to 264.6  14.3 
%, p< 0.001 (2x above basal levels) which was partially inhibited by lithium, carbamazepine 
or valproate (lithium: 160.7  25.6 %, p< 0.001; carbamazepine: 143.9  13.1 %, p< 0.001; 
valproate: 195.4  21.8 %, p< 0.05) although no effect was observed by these drugs on the 
basal cAMP production. Quinpirole, had no effect on the basal cAMP accumulation (data 
not shown); however, this dopamine D2-receptor agonist inhibited isoproterenol-enhanced 
cAMP levels in untreated neurons (158.4  16.8 %, p< 0.001) and this effect was decreased in 
neurons pre-exposed to lithium, carbamazepine or valproate (lithium, 249.1  28.4 %, p< 
0.05; carbamazepine, 243.8  21.5 %, p< 0.05; valproate, 259.0  18.4 %, p< 0.01) (Figure 16). 
To complement these results, in vivo studies were also performed. Preliminary experiments 
showed that 180 min after probe insertion cAMP levels were stable and were maintained 
throughout the experiment being the basal cAMP levels for control animals 9.68 ± 2.10 fmol/20 
µL, not different in valproate-treated rats, but significantly increased in lithium-treated, 13.17 ± 
1.21 fmol/20 µL (p< 0.05) and decreased in carbamazepine-treated rats, 7.82 ± 0.34 fmol/20 µL 
(p< 0.01).  
The concentrations of 2.5 mmol L-1 and 100 µmol L-1, respectively, for isoproterenol and 
quinpirole were used in all in vivo experiments (Figure 17), as they were found to be the 
minimal concentrations that produced an observable effect under our experimental 
conditions (Mørk and Geisler, 1994). 
After 30 min of isoproterenol infusion in the prefrontal cortex of control and vehicle-treated rats 
an increase in cAMP levels to, respectively, 234.6 ± 12.2 % and 272.1 ± 12.0 % (Figure 17 A,D) of 
the basal values occurred, and this effect was significantly decreased in rats pre-treated with the 
three drugs (lithium: 131.9 ± 5.8 %, p< 0.01; carbamazepine: 159.0 ± 8.5 %, p< 0.01; valproate: 
137.9 ± 8.7 %, p< 0.01 (Figure 17 B,C and E). A decrease was also observed in the total 
isoproterenol-evoked increase in the extracellular cAMP (lithium: 85.1 ± 3.7 %, p< 0.01; 
carbamazepine: 87. 5 ± 1.6 %, p< 0.05; valproate: 69.5 ± 2.4 %, p< 0.001), when compared to 
control or vehicle-treated rats values (Figure 17 A,D), similarly to what happened in the ex vivo 
studies. When both isoproterenol and quinpirole were locally infused, the effect of the D2-like 
receptors agonist significantly inhibited the effect of isoproterenol-induced increase of 
extracellular cAMP (control rats: 132.5 ± 5.8 %, p< 0.01; vehicle-treated rats:  141.0 ± 9.1, p< 0.01) 
measured 30 min after the agonist infusion (control rats: 77.0 ± 1.6 %, p< 0.001; vehicle-treated 
rats:  74.9 ± 2.7, p< 0.001) (Figure 17 A, D) and the total increase in extracellular cAMP evoked 
by isoproterenol within 150 min (Figure 17 F)). In lithium-treated rats the activation of D2-like 
receptors did not inhibit the isoproterenol-induced increase in extracellular cAMP as 
demonstrated by measurements 30 min after infusion (188.2 ± 19.1 %, p< 0.01 (Figure 17 B), vs 
control 132.5 ± 5.8 % (Figure 17 A) or lithium- treated animals infused only with isoproterenol 
(131.9 ± 5.8 %) (Figure 17 B) and the total extracellular cAMP produced within 150 min (77.0 ± 
1.6 vs 94.7 ± 4.4 %, p< 0.01, (Figure 17 F), as it was observed in cortical neuron cultures. In 
contrast to the behaviour of the three drugs in the ex vivo studies and in lithium-treated rats, in 
carbamazepine- or valproate-treated animals, quinpirole did not significantly change the 
isoproterenol-induced increase in extracellular cAMP (176.9 ± 8.3 % and 158.0 ± 11.7 %, 
respectively (Figure 17 C ,E)  vs control 132.5 ± 5.8 % , vehicle-treated rats 137.9 ± 8.7 %,  (Figure 
17 A,D), or carbamazepine- 159.0 ± 8.5 % or valproate - treated  rats 137.9 ± 8.7 %, and infused 
only with isoproterenol (Fig. 3C and E) produced 30 min post-infusion, or the total evoked 
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extracellular accumulation of cAMP measured during 150 min following infusion with 
quinpirole and isoproterenol (84.7 ± 3.5 % and 85.9 ± 2.2 %, respectively vs control 77.0 ± 1.6 % 
and vehicle-treated rats 74.9 ± 2.7 %, (Figure 17 F). As a control, it was observed that the 
activation of D2-like receptors had no effect on basal cAMP levels under control conditions 
(control rats: 100.4 ± 18.4 %; vehicle-treated rats:  104.0 ± 11.3 %) but in lithium-treated rats the 
activation with quinpirole, significantly increased cAMP levels to 155.1 ± 9.3 %, p< 0.05 and in 
carbamazepine- and valproate-treated rats the basal cAMP levels didn’t significantly change 
(114.4 ± 8.9 % and 98.7 ± 13.6 %, respectively vs 100.4 ± 18.4 % and 104.0 ± 11.3 %). 
 
Fig. 17. Effect of the local infusion of isoproterenol (2.5 mmol L-1) or quinpirole (100 µmol L-1) 
simultaneously with isoproterenol (2.5 mmol L-1) (starting at arrow) on the maximal 
extracellular cAMP levels produced 30 min post-infusions (a) control rats; b) lithium-treated 
rats; c) carbamazepine-treated rats; d) vehicle-treated rats; e) valproate-treated rats) and on 
total cAMP levels (correspondent to the area under the curves), measured within 150 min post-
infusions (f). Basal cAMP level was taken as the average cAMP concentration in the four 
consecutive samples collected from 3 h after the insertion of the probe, prior to isoproterenol 
(8.9 ± 2.6 fmol/20 µL, n= 6) and quinpirole plus isoproterenol infusions (9.4 ± 1.1 fmol/20 µL, 
n= 4). Thereafter, the agent of interest (2.5 mmol L-1 isoproterenol or 100 µmol L-1 quinpirole 
plus 2.5 mmol L-1 isoproterenol) dissolved in Ringer solution was infused through the probe, 
for 30 min, and seven samples were then collected. Extracellular cAMP levels in the dialysates 
were measured by radioimmunoassay analysis and expressed as percentages of the basal 
value (a)-e)) or expressed as a percentage of the percentage of the total amount of cAMP 
produced during 150 min post-infusion with isoproterenol in control or vehicle-treated rats (f). 
Results are means  SEM, from 4 to 6 independent experiments. The rats were treated or not 
with doses yielding therapeutic plasma levels of lithium, carbamazepine or valproate, during 
three weeks, as indicated in (Montezinho et al., 2006). Data are analyzed by one-way ANOVA, 
followed by post-hoc Bonferroni’s test for multiple comparisons. ***, p< 0.001; compared to the 
cAMP produced 30 min after the infusion of isoproterenol in control rats. +++, p< 0.001; 
compared to the cAMP produced 30 min after the infusion of isoproterenol in vehicle-treated 
rats. §§, p< 0.01; compared to the cAMP produced 30 min after the infusion of quinpirole plus 
isoproterenol in control rats. &&, p< 0.001; compared to the cAMP produced 30 min after the 
infusion of quinpirole plus isoproterenol in lithium-treated rats (Montezinho et al., 2006). 
www.intechopen.com
 Bipolar Disorder – A Portrait of a Complex Mood Disorder 
 
88
Taken together, ex vivo and in vivo data showed that stimulation of -adrenergic receptors 
with isoproterenol increased cAMP levels and this effect was significantly inhibited by 
lithium, carbamazepine or valproate. The activation of dopamine D2-like receptors with 
quinpirole decreased the isoproterenol-induced raise in cAMP in control conditions. This 
inhibition was observed in vivo after chronic treatment of the rats with carbamazepine or 
valproate, but not after treatment with lithium or in cultured rat cortical neurons after 48 h 
exposure to the three mood stabilizers. 
Immunohistochemistry studies (data not shown) (Montezinho et al., 2006) confirmed the co-
existence of dopamine D2 and 1-adrenergic receptors in the majority of the cells of the rat 
prefrontal cortex, allowing the interactions at the second messenger level. The results 
obtained from prefrontal cortex sections of lithium- carbamazepine or valproate-treated 
suggested a loss of dopamine D2 receptors, whereas in valproate-, carbamazepine-, and 
lithium-treated rats the 1-adrenergic receptors seemed to be, respectively, down-regulated, 
upregulated or not changed (Montezinho et al., 2006).To confirm these data, the levels of the 
dopamine D2 and 1-adrenergic receptor proteins were determined in membranes prepared 
from cultured rat cortical neurons and from rat prefrontal cortex, pre-treated or not with the 
mood stabilizing agents, by western blot analysis, using the same anti-D2 and anti-1 specific 
antibodies used for immunohistochemistry. An evident immunoreactivity was observed at 
50 kDa and 64 kDa, the predicted molecular weights for the dopamine D2 and 1 
adrenergic receptor proteins, respectively, in protein extracts from cultured rat cortical 
neurons and from cortex of rats treated with the three drugs (data not shown) (Montezinho 
et al., 2006). The quantitative analysis of these bands, by densitometry, confirmed that 
lithium, valproate and carbamazepine treatments significantly decreased dopamine D2 
receptor protein levels in membranes from treated cultured rat cortical neurons and in 
prefrontal cortex of treated animals when compared with control values. Concerning 1-
adrenergic receptors only valproate decreased the expression of the receptor present in 
cultured cortical neurons; however, in vivo treatment with carbamazepine, valproate or 
lithium, up-regulated, down-regulated or had no effect on 1-adrenergic receptor levels, 
respectively, when compared with control and vehicle-treated rats (data not shown) 
(Montezinho et al., 2006). 
In conclusion, this study shows that there is a cross-talk between dopamine D2-like and -
adrenergic receptors activities in the rat brain cortical region, which is differentially affected 
by therapeutic concentrations of the mood stabilizing drugs lithium, carbamazepine and 
valproate. Indeed, in vivo and in vitro data showed that activation of dopamine D2-like 
receptors inhibits 1-adrenergic receptor stimulated cAMP production. Ex vivo this 
inhibition was attenuated by lithium, carbamazepine and valproate, whereas in vivo only 
lithium had such effect. Consistent with this regulatory role on AC activity, dopamine D2 
and 1-adrenergic receptors are co-localized in the rat prefrontal cortex and their protein 
levels are changed by mood stabilizers as determined by immunohistochemistry and 
immunoblotting, respectively.  
These data show that the three mood stabilizers affect dopamine D2 ‐like receptor‐mediated 
regulation of ‐adrenergic signalling, both ex vivo and in vivo although in a different way. The 
discrepancy between ex vivo and in vivo results can be explained through at least three factors: 
the cellular interactions in the 3D structure of intact rat brain are different from those in a 2D 
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typical organization of neuronal cultures (Dziedzicka‐Wasylewska et al. 1996; Ichikawa & 
Meltzer 1999); the absence of glial cells, which contain ‐adrenergic and D2 ‐like receptors 
(Stone & John 1990; Stone et al. 1990), in the cortical neuron cultures used;  cortical neuron 
cultures were exposed to the mood stabilizing agents for 48 h whereas the animals were 
treated with the same drugs during three weeks and, according to literature data, the 
mechanisms involved in acute and chronic Li+ treatment are different (Mørk & Geisler, 1987b, 
1989c; Newman & Belmaker, 1987). This highlights the importance of the in vivo studies. Each 
of these drugs acts by a unique mechanism in vivo: chronic treatment with lithium increases 
cAMP levels which may be attributed to the inhibition of Gi,  (Jope, 1999a; Masana et al., 1991, 
1992; Montezinho et al., 2004); however, taking into account data here presented, the loss of 
dopamine D2-like receptors, which are coupled to the inhibition of AC,  may also account for 
the increase in the basal cAMP levels, thus mediating lithium antimanic action (Schatzberg et 
al., 2004; Silverstone and Silverstone, 2004; Yatham et al., 2002),. In contrast with lithium, in 
vivo carbamazepine treatment decreases cAMP levels despite an observed increase in the 1 -
receptor expression. This effect may be exerted primarily at the level of cAMP production, by 
the direct inhibition of AC (Chen et al., 1996a), which can also explain the attenuated 
isoproterenol-evoked cAMP production and the lack of a further effect of D2 receptor 
activation. The changes in receptor levels could represent a compensatory mechanism in the in 
vivo conditions. In vivo administration of valproate significantly reduced both the 1-
adrenergic and dopamine D2 receptor levels, which can explain the decrease in isoproterenol-
evoked receptor-mediated cAMP production, and no further attenuation  of cAMP production 
after dopamine D2 receptors stimulation. The -adrenergic down regulation by valproate was 
also showed in vitro (Chen et al., 1996b). 
These findings suggest that additional mechanisms are operative in vivo as compared to in 
vitro. It can be speculated that dopaminergic and noradrenergic neurotransmitter levels 
released by afferent projections participate in the regulation of these monoaminergic 
systems. In agreement with this hypothesis, a decrease in the dopamine concentration in 
prefrontal cortex and an increase in striatum (Dziedzicka-Wasylewska et al., 1996) were 
reported after the in vivo intragastrical administration of lithium. In contrast, it was 
described that therapeutic concentrations of carbamazepine or valproate enhanced basal 
releases of dopamine in the prefrontal cortex (Ichikawa & Meltzer, 1999). In addition, 
carbamazepine and valproate are metabolized in vivo, what might contribute to the 
differences observed in the effects of these drugs in vitro and in vivo. Moreover, the presence 
of glia cells expressing 1-adrenergic (Stone et al., 1990; Stone & John, 1990) and D2 receptors 
(Khan et al., 2001) in rat brain cortex increases the complexity of the regulation of the cAMP 
levels in vivo when compared with the in vitro data. Lastly, the other D2-like receptor 
subtypes, namely the D3 and D4 receptors, and the 2 and 3-adrenergic receptors may also 
play a role in the regulation of cAMP levels and the expression pattern of these receptors in 
vitro may be different from the one observed in vivo.  
It has been described that the function of the -adrenergic receptor signalling in the striatum 
and prefrontal cortex depends upon dopaminergic activity (Herve et al., 1990). Thus, 
treatments affecting dopaminergic neurotransmission can influence the success and the 
rapidity of action of mood stabilizing drug therapy. These results support the hypothesis 
that therapeutic intervention in bipolar disorder may be improved by affecting -adrenergic 
receptor signalling via effects on dopamine D2 receptor pathways.  
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5. Conclusions 
The work presented in this chapter focused on Li+ effects on several cellular systems and in 
vivo, in particular how it affects intracellular Mg2+ binding, cell energy metabolism, 
GABAergic and glutamatergic neurotransmitter systems, intracellular cAMP levels and their 
modulating systems, contributing to a better understanding of Li+ action in bipolar disorder. 
The results showed that: 
 Under depolarising conditions, the Na+/Ca2+ exchanger is proposed to be the new 
contribution to Li+ influx, resulting from the activation of L-type voltage-sensitive Ca2+ 
channels, where Li+ replaces Na+. 
 Li+ intracellular immobilization is cell type dependent. 
 Li+ is able to displace Mg2+ from its intracellular binding sites, providing further 
evidence for the generality of the ionic Li+/Mg2+ competition mechanism. The extent of 
Li+/Mg2+ competition was suggested to be cell-type dependent, being affected by 
differences in Li+ transport and immobilization properties. 
 Li+ had a remarkable inhibitory effect on the energetic metabolism of glucose in SH-
SY5Y cells. The results were consistent with an inhibition of glycolytic and TCA cycle 
fluxes, with an unchanged intracellular redox state. Li+ did not interfere with the 
competitive metabolism of glucose and lactate, or the residual contribution of unlabeled 
endogenous sources for the acetyl-CoA pool.  
Similarly to SH-SY5Y cells, but to a much lesser extent, neuronal glycolytic flux was 
also found to be decreased in cultured rat cortical neurons after incubation with 15 
mmol L-1 Li+. 
 Li+ decreased the incorporation of 13C labeling into GABA carbons from its precursor 
glutamate in neurons, both in vivo and ex vivo, suggesting an inhibitory effect on 
glutamate decarboxylase. 
 Li+ plays an important role in the homeostasis of the second messenger cAMP in 
neuronal cells (Fig. 18 B) a.).  
 In cultured cortical neurons the mood stabilizing drugs Li+, valproate and 
carbamazepine do not affect basal cAMP levels, although in vivo different effects are 
observed. The increase in ‐adrenergic‐ and forskolin‐mediated production of cAMP is 
attenuated by the three drugs both ex vivo and in vivo (Fig. 18 B) b.). 
 The three mood stabilizers act on the dopamine D2‐like and ‐adrenergic 
receptor‐mediated regulation of cAMP levels both in vivo and ex vivo (Fig. 18 B) b.), but 
by different mechanisms. This may explain the differences in their efficacy in the 
treatment of manic episodes in clinical cases.  
Fig.18 summarizes some of the results obtained concerning targets and effects of Li+, 
carbamazepine and valproate. 
This work is a contribution to clarify some of the hypotheses that have been advanced for 
Li+ action namely the ionic competition model, the effects on energetic metabolism and on 
signal transduction pathways. Li+ acts on multiple targets and interferes with many 
biological processes. Although biological effects cannot be studied isolated, the data 
presented are some pieces to join the puzzled information in the literature, which hopefully 
will help to make “the whole story” - a step forward to establish the general mechanism of 
action of this ion in bipolar disorder. 
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Multinuclear NMR spectroscopy was found to be a powerful tool in the study of Li+ 
transport, Li+ immobilization and Li+ effects on different metabolic pathways involved in 
cell energy production and signalling. Application of mathematical models to 13C NMR data 
obtained from cultured brain cells and rat brain in vivo seems to be a promising strategy to 
identify, more precisely, the metabolic pathways specifically affected by Li+.  Microdialysis 
in freely moving animals showed to be very useful for the in vivo quantification of 
neurotransmitters, providing information about signal transduction processes. 
   
(A) (B) 
Fig. 18. A) Signal transduction cascades involved in the pathophysiology of bipolar disorder 
(alterations represented by ↑↑) and in the therapeutic action of mood-stabilizing agents (Li+), 
valproate (VPA) e carbamazepine (CBZ) (represented by the red lines (inhibition) and blue 
arrow (activation). Li+ and VPA activate phosphodiesterases (PDE) which hydrolyze 3’5’-
cyclic-adenosine monophosphate (cAMP), and the three mood stabilizing agents reduce the 
activity of adenylate cyclase (AC). Li+ inhibits the activity of stimulatory and inhibitory G 
proteins (Gs e Gi), which is explained through Li+/Mg2+competition. These alterations 
contribute to the reduction of protein kinase A (PKA) activity decreasing its 
phosphorylation capacity and originating long term perturbations. Phosphatases (PPs) 
convert phosphoproteins (P-proteins) in the dephosphorylated form (DP-protein). cAMP is 
hydrolyzed to 5’-AMP by phosphodiesterases (PDE) (Jope 1999a; Manji et al., 1995, 2001). B) 
a) The activation of adenylate cyclase (AC) with forskolin increases Li+ uptake  by SH-SY5Y 
cells and by cultured hippocampal and cortical neurons, at therapeutic concentrations of this 
cation. The inhibitory of the Na+/Ca2+ exchanger, KB-R7943, reduces Li+ influx under 
resting conditions and completely inhibits the effect of forskolin on the accumulation of this 
cation. Inhibition of N–type voltage-sensitive Ca2+ channels (VSCC), with -CgTx GVIA, or 
inhibition of protein kinase A (PKA) with KT-5720, also abolishes the effect of forskolin on 
Li+ uptake. The effect of cAMP in SH-SY5Y cells is mediated by PKA and occurs via changes 
in the intracellular free concentration ([Ca2+]i). Accordingly, intracellular accumulation of 
cAMP seems to increase the [Ca2+]i due to Ca2+ entre through N-VSCC, which activates the 
Na+/Ca2+ (Li+/Ca2+ exchanger in order to extrude the Ca2+ taken up by the cells. b) Direct 
stimulation of AC with forskolin increase cAMP levels both in vitro and in vivo, and this 
effect was significantly inhibited by Li+, valproate and carbamazepine. In carbamazepine-
treated animals, the activation of dopamine D2-like receptors enhances the responsiveness of 
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AC to activation by forskolin, possibly as a consequence of chronic inhibition of the activity 
of this enzyme. An increase in the activation of AC and cAMP production is described as a 
super-sensitization of AC. In vivo, each of the mood stabilizing drugs modulates dopamine 
D2-like (D2) and -adrenergic (A) receptor-regulated cAMP levels by a distinct mechanism. 
The effects of carbamazepine are most likely due to direct inhibition of AC, whereas Li+ may 
act by affecting dopamine D2 receptor mediated signalling and valproate by down-
regulating -adrenergic transmission.
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